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ABSTRACT 
 
 Most animals rely on the olfactory system to detect chemical information about 
their environment to properly respond to cues. In mice, two systems, the main olfactory 
system and the accessory olfactory system, detect odors and relay information about 
food, danger, predators, and other animals.  
 The main olfactory system consists of olfactory sensory neurons (OSNs) located 
in the nose, which detect odors that diffuse into the nasal cavity and send signals to the 
olfactory bulb of the brain. OSNs express one receptor and precisely target to respective 
regions of the olfactory bulb. These targeting events are finely regulated and the factors 
that influence these events are of great interest to study. Olfactory ensheathing cells 
(OECs) surround OSN axons along their targeting routes and have been shown to 
promote proper axon extension and growth. I have identified the unique expression of a 
glutamate receptor subunit, GluN3A, in OECs and using genetic methods, ablated 
GluN3A in these cells and studied the consequences in OSN axon targeting to the 
olfactory bulb. 
 The accessory olfactory system consists of vomeronasal sensory neurons (VSNs) 
that are located in a sequestered organ found in the nasal cavity, called the vomeronasal 
organ (VNO). These neurons detect pheromones from other animals to elicit distinct 
mating and aggressive behaviors in many species, and project their axons to a specialized 
region of the olfactory bulb called the accessory olfactory bulb (AOB). This system is 
less studied than the main olfactory system, and I sought to characterize the process of 
pheromone delivery to these neurons. Since the VNO is isolated from the environment, 
the method of pheromone delivery is an active process. I have identified the expression of 
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phosphodiesterase 5A (PDE5A) in the VNO blood vessel, and using pharmacological 
methods to inhibit PDE5A, showed that the activity of this enzyme is important for 
pheromone delivery to the VNO.  
 Overall, I have analyzed two proteins that have not been previously characterized 
in the olfactory system of mice and have shown the consequences of perturbing these 
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Overview and Significance	  
 The sense of smell is an important chemosensory system that detects odors to 
relay information to an organism’s brain about external cues in the environment. Most 
odors are complex combinations of multiple chemical compounds that provide 
information about danger, food, and potential mates (Hildebrand and Shepherd, 1997). In 
vertebrates, two olfactory systems exist to detect odors from the environment and relay 
these cues to the brain. The main olfactory system contains olfactory sensory neurons 
(OSNs), which transduce chemical odors that enter the nasal cavity into electrical signals. 
These electrical signals are sent to the olfactory bulb (OB) of the brain, and then on to 
other areas of the brain to mediate appropriate behaviors. This system has been well-
studied - the signal transduction mechanisms of the OSNs have been well-described, as 
well as the relaying of these messages to deeper areas of the brain, and the roles this 
signaling plays in overall responses to odorant cues. I will further examine this system, 
characterizing OSN targeting specifically in Chapter 5. 
 The secondary olfactory system, the vomeronasal system (which I explore further 
in Chapters 2-4), exists in non-primate mammalian species. This system predominantly 
detects pheromones from the animal’s environment, and ultimately sends signals to the 
areas of the brain involved in innate behavioral responses, especially those involving 
mating or aggression (Wysocki, 1979, Wysocki and Lepri, 1991, Wysocki et al., 1982, 
Beauchamp et al., 1982, Beauchamp et al., 1985, Lepri and Wysocki, 1987). In the past 
couple of decades, studies have unveiled several processes and molecular components 
involved in the detection and processing of pheromones in an animal (Keverne, 1998, 
Liman, 1996, Stowers et al., 2013, Touhara, 2008). As many of the molecular 
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components have only recently been identified, their role in pheromone processing has 
not been fully elucidated.  
 The work presented here describes the novel expression of two proteins in the 
olfactory systems of mice and examines their function in olfaction. The first protein, 
phosphodiesterase 5A (PDE5A), was found in the blood vessel of the vomeronasal organ 
(VNO) (detailed in Chapters 2-4), and we have demonstrated its importance for the 
regulation of pheromone delivery to the VNO for detection. The second protein, 
glutamate N-methyl-D-aspartate receptor 3A subunit (GluN3A), was found in a subset of 
olfactory ensheathing cells of the main olfactory system. In Chapter 5, we show that 
GluN3A is not required for proper OSN targeting to the olfactory bulb, as previously 
expected, thus its importance and function in these cells still remains elusive.  
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The Main Olfactory System	  
 The main olfactory system detects chemical odors from the environment to 
provide an animal with information about danger, food, and other animals. This system is 
composed of a pseudo-stratified olfactory epithelium (OE) that is primarily composed of 
olfactory sensory neurons (OSNs), which detect odors that diffuse into the nasal cavity 
(Vassar et al., 1993). OSNs exhibit a bipolar structure where each OSN projects one 
dendrite to the apical surface of the epithelium where it terminates at a structure called 
the dendritic knob. Multiple cilia emanate from the dendritic knob into the mucosa of the 
nasal cavity. As an odor enters the nasal cavity, it binds one cognate receptor located on 
the cilia and triggers a signal transduction cascade in the OSN that depolarizes the 
neuron. The OSN then transmits this electrical signal through an axon that projects 
through the basal lamina, along the olfactory nerve and ultimately, to the olfactory bulb 
of the brain.  
OSNs project their axons onto specified neuropil structures in the OB called 
glomeruli, where they then synapse onto mitral cells (Mombaerts, 1996, Mombaerts et 
al., 1996). Each OSN expresses only one odorant receptor type out of over a thousand 
possibilities (Buck and Axel, 1991, Zhang and Firestein, 2002, Zhang et al., 2004) OSNs 
expressing the same receptor are stochastically distributed throughout the olfactory 
epithelium (Vassar et al., 1993), but extend axons to the same glomerulus in the olfactory 
bulb (Mori et al., 1999). The process of receptor choice and the precise targeting with 
other OSNs are quite remarkable processes, and many critical axon guidance factors have 
been identified (Cloutier et al., 2002, Cloutier et al., 2004, Culotti and Kolodkin, 1996, 
Cutforth et al., 2003, Kolodkin, 1996, Kolodkin, 1998). The role of olfactory ensheathing 
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cells (OECs), a particular type of glial cell, has also been shown to be critical for the 
proper targeting of OSN axons; however, the exact mechanisms by which OECs promote 
axon growth and targeting is not well established.  
 
Olfactory ensheathing cells promote proper OSN targeting during the development 
of the olfactory system and regeneration after tissue damage  
Olfactory development in the mouse initially begins around 9 days post 
fertilization, when regions of the neural plate specified to become the olfactory placode 
migrate out of the neural tube (Cuschieri and Bannister, 1975a, Cuschieri and Bannister, 
1975b). Cells from the olfactory placode differentiate into OSNs around this time and 
begin expressing OSN-specific markers around E10-10.5 (Cuschieri and Bannister, 
1975a, Cuschieri and Bannister, 1975b). The presumptive olfactory epithelium and 
vomeronasal neuroepithelium are distinguishable around E11.5-E12 based upon their 
general anatomical structure. Following this differentiation event, OSNs begin migrating 
toward the unformed olfactory bulb structure as a group termed the “migratory mass”	  
(Santacana et al., 1992, Valverde et al., 1992). This mass consists of not only migrating 
OSN axon bundles, but also supporting glial cells, although the exact roles of these glial 
cells in this migration event are not fully understood.  
These migratory glial cells (likely precursors to olfactory ensheathing cells) and 
axons migrate and extend toward the rostral-most region of the telencephalon around 
E11-11.5 (Lopez-Mascaraque et al., 1996, Treloar et al., 1996, Whitesides and LaMantia, 
1996), where they then halt in the presumptive olfactory nerve layer region until the 
formation of glomerular targets occurs around E15 (Akins and Greer, 2006). The purpose 
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for this distinct halt in migration is still largely unknown; however, it is currently 
hypothesized to be involved with the sorting of OSN axons based upon receptor 
expression, allowing for glomerular targeting that takes place shortly after this time 
(Treloar et al., 1999). This establishes the organization of the olfactory bulb, with most of 
the major connections having been established prior to birth, although axon targeting and 
sorting continues throughout the lifespan of an animal, especially after OSN regeneration. 
Studies have shown that OSN axonal targeting is partially controlled by the amino 
acid sequence of the receptor that the OSN expresses (Feinstein and Mombaerts, 2004, 
Rodriguez-Gil et al., 2015, Wang et al., 1998), exposure to particular odorants (Feinstein 
et al., 2004), and the expression of both general and olfactory-specific axon guidance 
cues such as NCAM (neuronal cell adhesion molecule) (Treloar et al., 1997), OCAM 
(olfactory cell adhesion molecule) (Walz et al., 2006), semaphorins (Taniguchi et al., 
2003, Cloutier et al., 2004), ephrins (Cutforth et al., 2003), and neuropilins (Cloutier et 
al., 2002, Giger et al., 2000). Many studies have also shown the importance of olfactory 
ensheathing cells in the proper sorting of OSN axons, where ablation of these cells 
prevents the axons from reaching their final targets (St John et al., 2003). 
OECs closely associate with OSN axons throughout the entire axonal path from 
the lamina propria of the mucosa all the way to the OB. In the OB, OECs (Figure 1.1, 
blue layer of cells) accompany OSN axons in the olfactory nerve layer until the axons 
reach their final targets, the olfactory glomeruli (Figure 1.1). It is thought that by 
enveloping OSN axons along their entire length, OECs isolate OSN axons from other 
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Schematic of the olfactory bulb (OB). Expanded region of the OB shows OSN axons 
(green and red) traveling from the olfactory epithelium (not shown) in nerve bundles 
ensheathed by olfactory ensheathing cells (OECs, blue). Axons pass directly through this 
novel layer of OECs and target to specific glomeruli in the glomerular layer (GL) of the 
OB where they synapse onto mitral cells (orange) located in the mitral cell layer of the 
OB.  
 
*OECs surrounding the OSN axon bundles aren’t included in this diagram for simplicity.  
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(Lipson et al., 2003, Ramon-Cueto and Avila, 1998, Zhu et al., 2010). Consistently, it has 
been shown that OECs express a range of proteins that function to facilitate axonal 
outgrowth and proper axonal fasciculation. These proteins include cell adhesion 
molecules, extracellular matrix proteins, neurotrophic factors, and Wnt family growth 
factors (Rodriguez-Gil and Greer, 2008, Wang et al., 2008). Further supporting this role, 
when injected into the gap between the dura mater and the cribiform plate, OECs can 
promote axon regeneration into the OB following olfactory nerve transection in rats (Wei 
et al., 2008). However, the mechanisms by which OECs impart the formation of such 
precise connections during development and upon regeneration remain largely unknown.  
OSNs are a dynamic population of neurons, with neurogenesis occurring not only 
during development, but also throughout adulthood. The presence of stem cell-like 
horizontal basal cells grants a remarkable ability of the epithelium to replenish its 
neuronal population after damage (Schwob, 2002, Leung et al., 2007). Upon damage, 
basal stem cells receive signals from their environment to undergo regeneration (Beites et 
al., 2005). The newly regenerated OSNs must then progress through the same OSN 
maturation processes as those occurring during development, including odorant receptor 
choice and re-targeting to the appropriate glomerular target in the OB. These regenerated 
OSNs can make precise glomerular connections with mitral cells in the OB and are able 
to fully restore the function of the olfactory system after damage (Gogos et al., 2000).  
 
OEC heterogeneity 
Although OECs are able to fully repair the olfactory system, experiments using 
OECs to facilitate repair of other neurons after injury, specifically spinal cord injuries 
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(see Chapter 6) suggests that there is extensive heterogeneity within the OEC population. 
Previous studies have shown that OECs consist of multiple subtypes that are 
differentiated by their diverse olfactory nerve localization, morphology, gene/protein 
expression, and function (Wang et al., 2008). It is well established that OECs in the 
olfactory mucosa and the OB are different (Jani and Raisman, 2004, Richter et al., 2005, 
Windus et al., 2010). Within the olfactory bulb, OECs in the outer and inner olfactory 
nerve layers are also different, where OECs in the outer olfactory nerve layer often 
express p75NTR, GFAP, and S100β (Forni and Wray, 2012), whereas OECs in the inner 
olfactory nerve layer often do not (Wang et al., 2008). Many OECs in the inner olfactory 
nerve layer instead express TROY, a member of the tumor necrosis factor receptor 
superfamily (Morikawa et al., 2008). Identifying OEC subtype specific marker(s) is a key 
step toward advancing the understanding of distinct biological functions and properties of 
the different OEC subtypes. Transcriptional profiling and proteomic analyses are also 
needed for such purposes. 
Our previous studies have revealed a novel subtype of OECs in the OB (Booker-
Dwyer et al., 2008) using a TOPGAL transgenic mouse line that reports nuclear β-catenin 
activity with β-galactosidase (β-gal) expression (DasGupta and Fuchs, 1999), which is 
often indicative of canonical Wnt signaling. These OECs are located at the interface of 
the OSN axon bundles and the nerve targets in the glomerular layer (Figure 1.1, blue cell 
layer), and display nuclear β-catenin activity. This β-catenin activity is limited to this 
subtype of cells in the entire OB and is seen predominantly during developmental stages 
when OSNs innervate their glomerular targets. No staining was present in the olfactory 
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epithelium at any time, suggesting that this Wnt expression is confined to OECs and not 
the OSNs.  
The spatial and temporal pattern of these β-gal positive cells during development 
thus suggests a role for these OECs in the formation of OSN connections in the OB. This 
same β-gal staining, indicating nuclear β-catenin activity, can also be seen during active 
stages of OSN regeneration in response to epithelium tissue damage (Booker-Dwyer et 
al., 2008). Together, the expression of nuclear β-catenin during regeneration and 
development in this non-neuronal cell population strongly implicates a function for these 
cells during olfactory axon targeting processes; however, the molecular mechanisms 
underlying these processes are not known. 
Two additional research groups independently reported a similar subtype of OECs 
in the OB (Rodriguez-Gil and Greer, 2008, Wang et al., 2008). The other groups found 
co-localization of this Wnt reporter with NPY and S100β (Wang et al., 2008), which was 
not observed in our laboratory when we co-stained our reporter mice with these OEC 
markers. Furthermore, we found that the majority of known OEC markers were not 
expressed in this OEC subtype (Booker-Dwyer et al., 2008). This combined with the 
conflicting reports of expression of known OEC markers have prompted us to investigate 
these OECs further with more sensitive methods to elucidate molecular properties that 
enable these cells to promote and guide sensory neurons to their targets. 
Using the Allen Brain Atlas, a public in situ hybridization database 
(http://developingmouse.brain-map.org/gene/show/88952), we searched for candidate 
genes that are expressed in OECs in the OB (described above). We found that GluN3a 
(also known as NR3A, Grin3a, or NMDAR3A), an N-methyl-D-aspartate (NMDA)-type 
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glutamate receptor subunit, is specifically expressed in the same location as this novel 
Wnt-expressing OEC subtype. We have confirmed the specific expression of GluN3a in 
the OB by in situ hybridization, and preliminarily show that no other NMDA receptor 
subunits (GluN1 and GluN2s) are expressed in the olfactory nerve layer where this novel 
OEC subtype resides. This is surprising and intriguing, as it has been shown that GluN1 
is required for assembling a functional hetero-tetrameric NMDA receptor and the only 
known role of GluN3A is to form functional NMDA receptors (Figure 1.2) (Furukawa et 
al., 2005). The identification of GluN3a in these OECs may provide a molecular marker 
for OECs of this subtype to distinguish them from other OEC subtypes in the OB, which 
I explore by examining the expression pattern of GluN3a in the olfactory system and the 
results of ablating GluN3A in the olfactory system.   
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GluN3A (red) is an NMDA receptor subunit that forms heterotetramers with assorted 
combinations of GluN1 (green) and GluN2 (blue) subunits to constitute a functional 
channel that binds glycine (pink circles) and glutamate (purple circles) and is permeable 
to calcium.  
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The Vomeronasal System	  
 The vomeronasal organ (VNO), which is also referred to as the organ of Jacobson 
(Jacobson et al., 1998), is a chemoreceptive olfactory structure that transduces chemical 
pheromones from the environment into electrical signals in the brain to mediate distinct 
innate social and mating behaviors. Pheromones are specialized compounds that elicit 
conspecific behaviors in mammals, reptiles, ungulates, etc. (Chamero et al., 2012, Johns, 
1986, Keverne, 2002b).  Fairly recently, the field has found pheromone-detecting 
receptors in the main olfactory epithelium (Date-Ito et al., 2008, Liberles, 2014); 
however, these receptors are not able to detect all classes of pheromones, as there are 
innate behavioral phenotypes associated with impairment of VNO function (Beauchamp 
et al., 1985, Curtis et al., 2001, Kiyokawa et al., 2007, Lepri and Wysocki, 1987, Wekesa 
and Lepri, 1994, Wysocki and Lepri, 1991).	  
 In most mammals, the VNO is a pair of tubular structures located in the anterior 
ventromedial portion of the nasal cavity (Figure 1.3) (Barrios et al., 2014, Doving and 
Trotier, 1998). The tubular wall is located on the medial side of the organ, and is 
composed of a crescent-shaped sensory neuroepithelium, where vomeronasal sensory 
neurons (VSNs) reside, and cavernous vascular tissue that is located laterally to the 
neuroepithelium (Figure 1.3 – inset). Each VNO tube is encapsulated by bone or cartilage 
with only the anterior end open to either the nasal cavity in rodents, or the oral cavity in 
other mammals. The tubular structure and the bony capsule surrounding the VNO 
sequester the sensory neurons from the external environment, necessitating active 
transport of pheromones into the VNO lumen, where they can then bind their cognate 
receptors on the sensory neurons.  
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Figure 1.3: The vomeronasal organ is a specialized sensory organ in the nasal cavity 











Diagram showing the location of the vomeronasal organ in the mouse nasal cavity. The 
expanded schematic shows a coronal section highlighting the general structure of the 
VNO. The sensory neuroepithelium (blue) contains VSNs that detect pheromones 
delivered to the lumen. The cavernous tissue (Cav, gray) is located on the lateral edge of 
the VNO and contains a primary blood vessel (BV) that is thought to actively constrict 
and dilate to draw pheromones from the nasal cavity into the organ for detection. For 
simplicity, only one side of the VNO is shown in the expanded image. 
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Vomeronasal sensory neurons in the VNO neuroepithelium detect pheromones and 
transmit signals to the brain	  
 The vomeronasal system contains sensory neurons located in the neuroepithelium 
of the organ. Vomeronasal receptors are G-protein coupled receptors (GPCRs), with three 
main classes identified in the VNO - those expressing the G protein, Gαi2, those 
expressing Gαo, and those expressing formyl peptide receptors (Berghard and Buck, 
1996, Chamero et al., 2011, Jia and Halpern, 1996, Oboti et al., 2014, Francia et al., 
2014, Liberles, 2014). Gαi2-expressing VSNs are located in the apical region of the 
VNO and consist of a smaller V1R receptor that detects lipophilic, volatile compounds 
(Boschat et al., 2002), whereas Gαo-expressing VSNs are located in the basal region and 
contain a V2R receptor with a longer N-terminal tail which detect many large urinary 
proteins (Ishii and Mombaerts, 2011, Yang et al., 2005). No overlap exists between these 
two regions in the neuroepithelium.  
As compared with OSNs in the main olfactory system, very little is known about 
the precise signal transduction events or machinery downstream of receptor binding in 
VSNs; however, recent work has identified key components essential for the events that 
lead up to the depolarization of the VSN (Berghard and Buck, 1996, Berghard et al., 
1996, Inamura et al., 1997a, Inamura et al., 1997b, Lucas et al., 2003). One of the main 
channels involved in this process is TRPC2 (transient receptor potential cation channel, 
subfamily C, member 2) (Leypold et al., 2002, Stowers et al., 2002), which was first 
shown to be highly expressed in VSNs by the Dulac lab in 1996 (Liman, 1996). Genetic 
ablation of this channel reduces innate pheromone-driven behaviors such as male-male 
aggression, and it appears that male mice are unable to differentiate the gender of other 
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mice, as they attempt to mate with other male mice, rather than demonstrating normal 
aggressive territorial behaviors. 
 Electrophysiological studies have also shown that the absence of TRPC2 
abolishes most, but not all, VSN responses to urine compounds (Leypold et al., 2002, 
Stowers et al., 2002). Overall, this suggests that TRPC2 in VSNs is required to enable 
proper depolarization and transmission of signals to the accessory olfactory bulb of the 
brain. Recent studies by the Mombaerts lab have shown expression of TRPC2 in a 
particular subset of OSNs in the main OE in mice and have argued that TRPC2 in OSNs 
may also be important for pheromone detection (Omura and Mombaerts, 2014, Omura 
and Mombaerts, 2015).  
  
Pheromone delivery to the VNO is dependent upon an active pumping mechanism	  
 Pheromone cues elicit very specific innate responses, depending upon the 
particular pheromone and the animal perceiving it. Many classes and subtypes of 
pheromones exist. Some pheromones are small, volatile molecules that can be detected 
by the main olfactory system (Perez-Gomez et al., 2015, Spehr et al., 2006a, Spehr et al., 
2006b, Liberles and Buck, 2006), but some pheromones are large, non-volatile molecules 
that are detected by the vomeronasal system. Accessory proteins called MuPs (major 
urinary proteins) are large proteins in urine that accompany pheromones for detection 
(Perez-Miller et al., 2010, Sharrow et al., 2003, Timm et al., 2001), but recently have 
been shown to stimulate VSNs themselves (Papes et al., 2010). These non-volatile 
pheromones are dissolved in fluid, and in order to be detected, the animal has to be in 
direct physical contact with the fluid containing the pheromones, as they cannot simply 
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diffuse into the VNO. The delivery of these compounds to VSNs is an active process, 
with a blood vessel-based pumping mechanism proposed to control this active delivery 
(Meredith, 1994, Meredith et al., 1980, Meredith and O'Connell, 1979). However, the 
molecular mechanisms regulating vascular dynamics and pheromone delivery in this 
system have not been fully elucidated. 
 It has been shown that sympathetic fibers from the nasopalatine nerve innervate 
the VNO blood vessel and are critical for pheromone delivery to the VNO (Meredith et 
al., 1980, Meredith and O'Connell, 1979). This sympathetic stimulation initiates 
vasoconstriction and parasympathetic fibers also innervating the blood vessel induce 
subsequent vasodilation (Eccles and Wilson, 1974, Meredith et al., 1980). Because the 
VNO is completely surrounded by rigid bony structures, this rapid cyclic vasoconstriction 
and vasodilation likely creates a negative pressure change within the lumen of the VNO, 
which is thought to be responsible for drawing fluid-containing pheromones into the 
lumen. The molecular components involved in regulating this vomeronasal pump or how 
these components affect pheromone sensing are unclear.  
 
Potential molecular mechanisms regulating the VNO pump	  
In the late 1990s, studies have identified the expression of neuronal nitric oxide 
synthase (nNOS) fibers in the blood vessel via immunohistochemistry for nNOS and 
nicotinamide adenine dinucleotide phosphate (NADPH) diaphorase staining, which is 
indicative of NOS activity (Zancanaro et al., 2002, Zancanaro et al., 1999). Even though 
these fibers were described previously and were characterized during various 
developmental time points in the mouse VNO, roles for nitric oxide signaling in the 
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regulation of the vasculature or glandular secretion were only suggested, and other 
molecular components involved in this process had not been identified.  
While performing a widespread phosphodiesterase reverse transcription 
polymerase chain reaction (RT-PCR) screen of all olfactory tissues, our laboratory 
noticed a high abundance of phosphodiesterase 5A (PDE5A) in VNO tissue (data not 
shown). Confirmation of this expression was further supported by an online database of 
microarray analyses (BioGPS – see Chapter 2 for details). While the relevance of PDE5A 
expression in the VNO was unexplored at that time, we were intrigued by this 
observation, as PDE5A has been shown to regulate blood vessel dynamics in many 
organs. My characterization of the expression pattern and significance of PDE5A in the 
VNO will be presented in Chapters 2-4. 
 
PDE5A regulates blood vessel tone 
 
 Proper regulation of blood vessel constriction and dilation is necessary for the 
delivery of nutrients around the body. The role of this regulation has been extensively 
studied in many organs, and has been a target for blood pressure-related disease. The 
landmark discovery of nitric oxide in the 1980s and its role in dilating blood vessels has 
revolutionized our understanding and focus of vascular-related disease and dysfunction 
(Moncada et al., 1988, Palmer et al., 1987). Since then, studies have focused on 
identifying potent drugs that target enzymes directly responsible for regulating nitric 
oxide signaling and its downstream components. 
Blood vessels are composed of an inner lining of endothelial cells (Figure 1.4, 
gray layer) directly surrounded by an elastic matrix-like structure termed the internal 
	  
	   19 
elastic lamina (IEL, Figure 1.4, dark red). Smooth muscle cells (SMC, Figure 1.4, pink) 
are innervated by sympathetic adrenergic fibers, and surround the IEL. The IEL functions 
as its name implies, and its elastic properties accommodate changes to the blood vessel 
upon the constriction and dilation of the smooth muscle cells in response to 
neurotransmitter release from nerve terminals. 
Due to concerns related to high blood pressure, many pharmaceutical drugs are 
focused on targeting pathways involved with controlling vasoconstriction and 
vasodilation to ameliorate this problem. We have taken advantage of the various 
pharmacological compounds available to examine the role of PDE5A in regulating the 
VNO pump, where it exhibits robust expression. This was a logical prediction, since 
PDE5A is known to regulate blood vessel constriction and dilation in several organs via 
its breakdown of cyclic GMP.  
 A substantial portion of this dissertation describes the expression of PDE5A in the 
VNO, and the use of pharmacological inhibitors of PDE5A, sildenafil citrate (Viagra™) 
and tadalafil citrate (Cialis™), to elucidate the role of PDE5A in the VNO (discussed in 
Chapters 2-4). Robust expression of PDE5A in the VNO along with other nitric oxide 
signaling components strongly suggests a potential molecular mechanism regulating the 
vascular dynamics of this blood vessel. Inhibition of PDE5A locally in the VNO 
attenuates the VNO pump, which results in a molecular and physiological consequence 
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The work described in this dissertation analyzes the novel expression pattern of 
two proteins and their potential functions in the olfactory systems in mice. Although 
these proteins have been well characterized in other systems, we wanted to further 
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Endothelial cells (gray) line the innermost wall of a blood vessel and are surrounded by 















































	   23 
ABSTRACT 
The vomeronasal organ (VNO) is a specialized chemoreceptive structure that 
detects pheromones. Pheromones are detected by the vomeronasal sensory neurons 
(VSNs) in this structure to elicit innate behaviors such as mating and aggression (Doving 
and Trotier, 1998, Jacobson et al., 1998, Dulac and Torello, 2003, Liberles, 2014, M, 
1987). Previous studies in rodents have demonstrated that pheromones are actively 
transported to the VNO via a blood vessel-based pumping mechanism and that this 
pumping mechanism is necessary for pheromone sensing (Meredith et al., 1980, Meredith 
and O'Connell, 1979, Meredith, 1994); however, the molecular mechanisms that regulate 
the vomeronasal pump remain largely unknown. This chapter describes the high level of 
expression of phosphodiesterase 5A (PDE5A) in the VNO blood vessel in mice and 
provides evidence to support an essential role of PDE5A for vomeronasal pump activity. 
Local application of PDE5A inhibitors, sildenafil or tadalafil, to the VNO attenuates 
stimulus delivery into the VNO, demonstrated by monitoring fluorescent fluid entry into 
the VNO. The current study advances our understanding of the molecular regulation of 
the VNO pump and describes the expression and characterization of potentially important 
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INTRODUCTION 
 
 Animals rely on odors from the environment for information about food, danger, 
and potential mates. In most mammals, in addition to the main olfactory system, an 
independent secondary olfactory system, the vomeronasal system, detects pheromones 
from the environment to elicit conspecific behaviors in the animal. The peripheral 
vomeronasal system consists of the vomeronasal organ (VNO), a pair of tubular 
structures located in the anterior and ventromedial portion of the nasal cavity (Figure 
2.1A) (Barrios et al., 2014, Doving and Trotier, 1998). Each VNO tube is encapsulated 
by bone or cartilage with only the anterior end open to either the nasal cavity in rodents 
or oral cavity in many other mammals. The wall of each VNO tube is comprised of 
sensory neuroepithelium along the medial area toward the septum and cavernous vascular 
tissue on the lateral sides. The vomeronasal sensory neurons (VSNs) reside in the sensory 
neuroepithelium and apically extend microvillar structures to the lumen upon which 
pheromones can bind specific receptors and send signals to the brain (Figure 2.1A – see 
inset). The tubular structure and the bony capsule surrounding the VNO sequester the 
sensory neurons from the external environment; therefore, pheromones cannot passively 
flow into the lumen. 
 The vomeronasal sensory system is not as well understood as the main olfactory 
system, but it is known that sniffing and breathing are not sufficiently effective for 
delivering pheromones to the sensory neurons in the VNO (Meredith and O'Connell, 
1979). The process of pheromone delivery to the sensory neurons therefore requires an 
active mechanism of transport. Only a few studies have examined the mechanism of 
pheromone delivery to the VNO, and have proposed that a blood vessel-based pumping 
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mechanism exists to draw in and expel pheromones from this structure (Meredith, 1994, 
Meredith et al., 1980, Meredith and O'Connell, 1979).   
 In this study, we found high expression of phosphodiesterase 5A (PDE5A) in the 
VNO blood vessel in mice. PDE5A is an enzyme that is well-known for regulating blood 
vessel tone. It catalyzes the break down of the cyclic GMP, leading to the constriction of 
blood vessels. Well-characterized inhibitors of PDE5A, such as sildenafil and tadalafil, 
have shown great effectiveness in promoting blood vessel dilation by inhibiting PDE5A 
in vascular smooth muscle cells (Cooke and Dzau, 1997, Gross and Wolin, 1995, 
Moncada and Palmer, 1991, Moncada et al., 1991). Using PDE5A-specific inhibitors, we 
wanted to elucidate the role of PDE5A in the blood vessel-based delivery of pheromones 
to the sensory neurons. We found that local inhibition of PDE5A in mice using these 
inhibitors, sildenafil and tadalafil, attenuated stimulus delivery into the organ. 
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RESULTS  
Molecular components of the VNO blood vessel 
 The main VNO blood vessel is composed of endothelial cells, which line the inner 
wall of the blood vessel (Figure 2.1B-C, green), and layers of smooth muscle cells 
(Figure 2.1B-C, red) (Canto Soler and Suburo, 1998), which are innervated by 
sympathetic (Figure 2.1D) (Canto Soler and Suburo, 1998, M, 1994, Meredith and 
O'Connell, 1979), and likely parasympathetic, fibers (Eccles, 1982, Meredith and 
O'Connell, 1979). Upon novelty or sexual stimulation, sympathetic axons innervating the 
tissue initiate constriction of the blood vessel (Meredith and O'Connell, 1979, Meredith, 
1994). This constriction should create a negative pressure in the organ, suctioning 
pheromones from the nasal cavity into the lumen, where they can then be detected by 
VSNs located on the neuroepithelium. VSNs transduce pheromones into neural electrical 
signals, which are sent to the accessory olfactory bulb (AOB) of the brain (Halpern and 
Martinez-Marcos, 2003, Wysocki, 1979). It has been demonstrated that this pumping 
mechanism is required for pheromone sensing (Meredith et al., 1980); however, little is 
known about the molecular mechanisms that regulate the VNO pump.  
 Immunohistochemical analysis of the VNO structure shows that sympathetic 
fibers from the nasopalatine nerve seem to closely associate with smooth muscle cells of 
the blood vessel, as opposed to the endothelial cells that line the innermost layer of the 
vessel (Figure 2.1B, C, D). The fibers appear to be distributed non-uniformly throughout 
the cavernous tissue (Figure 2.1E, red), where innervation is present most abundantly 
near the medial region of the blood vessel, and does not appear to overlap with the 
expression of neuronal nitric oxide synthase (nNOS, Figure 2.1E, green), which is also  
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Figure 2.1: Molecular components and innervation of the VNO blood vessel.       
(A) Diagram showing the location of the VNO in the mouse nasal cavity. Zoomed in – a 
coronal section schematic showing the blood vessel (BV)-containing cavernous tissue 
(Cav), the lumen, and the neuroepithelium, which contains the VSNs. (B, C) Coronal 
section of VNO tissue immunostained with CD31 (endothelial cells, green) and smooth 
muscle actin (smooth muscle cells, red) antibodies. (D) Coronal VNO section stained 
with tyrosine hydroxylase (TH, sympathetic nerves, green) and smooth muscle actin (red) 
antibodies showing the sympathetic innervation of smooth muscle cells in the blood 
vessel. (E) Coronal VNO section stained with nNOS (green) and TH (red) antibodies. (F) 
Coronal VNO section stained with NPY (green) antibody. (G) Coronal VNO section 
stained with GAD65 (glutamate decarboxylase, green) and ChAT (choline 
acetyltransferase, red) antibodies. (H) RT-PCR from heart, olfactory bulb (OB) and VNO 
tissue for nNOS. (I-J) RT-PCR from heart and VNO for eNOS (I) and iNOS (J). (K) 
Coronal section of VNO tissue immunostained with eNOS (green) and nNOS (red) 
antibodies. (L) Coronal section of VNO tissue immunostained with eNOS (green) and 
CD31 (red) antibodies. (M) RT-PCR from OB, VNO, and liver tissue for Gucy1b3.	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known to be expressed in the VNO blood vessel. Neuropeptide Y (NPY) fibers have been 
proposed to be important in the initial events involving VNO pump activation, and it 
appears that the fibers also innervate the blood vessel of the VNO. The pattern of 
expression is broader than sympathetic fibers, but appears to localize to the central and 
lateral areas of the cavernous tissue (Figure 2.1F). Smooth muscle also surrounds the 
entire VNO, even around the neuroepithelial region (Figure 2.1B, D). This elasticity 
surrounding the VNO suggests a mechanism by which the entire organ is able to expand 
and retract to draw pheromones into the lumen. Furthermore, we also characterized the 
expression of other enzymes such as GAD65 (glutamate decarboxylase 65, Figure 2.1G, 
green) and ChAT (choline acetyltransferase, Figure 2.1G, red).  
Over the past couple of decades, the processes involved with pheromone binding 
to vomeronasal receptors, vomeronasal sensory neuron molecular signaling in response to 
pheromone binding, and the downstream brain regions affected have been determined 
(Liberles, 2014); however, aspects of the vomeronasal system frequently overlooked are 
the molecular mechanism(s) involved with pheromone delivery to the sensory neurons.  
A couple of studies in the late 1990s have identified the expression of neuronal 
nitric oxide synthase (nNOS, also known as NOS-I) fibers in the VNO blood vessel via 
immunohistochemistry for nNOS and NADPH diaphorase staining (Kishimoto et al., 
1993, Kulkarni et al., 1994, Zancanaro et al., 2002, Zancanaro et al., 1999). Even though 
these fibers were reported in previous studies and characterized throughout various 
developmental stages in the rodent VNO, these findings only suggested a role for nitric 
oxide signaling in the regulation of the vasculature or glandular secretion. It is known 
that different types of nitric oxide synthases exist; however, studies only focused on the 
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expression of nNOS in the VNO. In our studies, we identified and elucidated the role of 
various molecular components in the VNO blood vessel. 
To first obtain an estimate of the relative abundance of the various NOS variants, 
we extracted total RNA from dissected VNO tissue. Using primers specific for nNOS, 
endothelial NOS (eNOS), and inducible NOS (iNOS), we performed reverse 
transcription-polymerase chain reaction (RT-PCR) with VNO tissue and other tissues 
known to express the various NOS types. As expected, we saw high levels of nNOS from 
VNO tissue and olfactory bulb tissue, which was used as a positive control (Figure 2.1H). 
Though less abundant, we also saw eNOS expression in VNO tissue and heart, the 
positive control for eNOS (Figure 2.1I).  Amplification of iNOS can be seen from VNO 
tissue (Figure 2.1J), albeit at very low levels, which is in agreement with data from 
publicly available microarray databases (Figure 2.2, BioGPS). Using an nNOS antibody, 
we have verified the presence of nNOS in the cavernous tissue of the VNO (Figure 2.1E, 
K), and have observed endothelial nitric oxide synthase (eNOS) in the endothelial cells of 
the VNO blood vessel (Figure 2.1K, L). Staining patterns showed that nNOS and eNOS 
localize to different cell types in the VNO blood vessel tissue. While this expression 
pattern is not surprising given the traditional architecture of generic blood vessels, the 
presence of eNOS in these endothelial cells provides evidence of a signaling mechanism 
for nitric oxide in the regulation of the VNO vasculature, and subsequently, the VNO 
pumping mechanism.  
We also examined various soluble guanylate cyclases, which are known to be 
responsible for the synthesis of cyclic GMP in response to nitric oxide production. We 
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find that Gucy1b3 is prevalent from isolated VNO tissue (Figure 2.1M). Olfactory bulb is 
used as a positive control and liver is used as a negative control for Gucy1b3 expression. 
 
PDE5A is highly expressed in the inner layer of cells lining the blood vessel of the 
VNO 
PDE5A has been shown to regulate blood vessel tone in many organs (Lin CS, 
2006, Kass et al., 2007). We therefore reasoned that PDE5A might also play a role in 
regulating the vomeronasal pump in a way similar to its typical function in vascular 
regulation. To determine the expression of PDE5A in the vomeronasal organ, we 
extracted total RNA from VNO tissue (with and without the bone surrounding the tissue 
removed) and performed RT-PCR on total RNA with two PCR primer pairs to amplify 
different regions of Pde5a transcripts. Pde5a cDNA was readily amplified from the VNO 
sample, and also from samples of bladder and penile tissue, which are known to express 
high levels of Pde5a (Lin et al., 2000, Morelli et al., 2004, Stacey et al., 1998), but not 
from the liver sample, which is known to express low levels of Pde5a (Giordano et al., 
2001, Stacey et al., 1998). We conducted PCR using 25 thermal cycles to avoid over 
amplification of the cDNA. Pde5a appears to be more robustly expressed in the VNO 
compared to the bladder and penile tissue (Figure 2.3A). This robust Pde5a expression in 
the VNO is consistent with publicly available microarray data from BioGPS 
(http://biogps.org/#goto=genereport&id=242202, dataset: GeneAtlas GNF1M, gcrma), 
which show that Pde5a is most highly expressed in the VNO among many organs, 
including the bladder (Figure 2.2). 
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Figure 2.2: BioGPS data (http://biogps.org/#goto=genereport&id=242202) showing 
high expression of Pde5a in the vomeronasal organ and relative abundance of 
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Figure 2.3: PDE5A is expressed in the vomeronasal organ and predominantly 
localizes to the inner layers of cells of the VNO blood vessel. 
(A) RT-PCR showing Pde5a expression in VNO, bladder, liver and penile tissue. PDE5A 
primer set 1 (top panel, expected band size of 767 bp) and PDE5A primer set 2 (middle 
panel, expected band size of 711 bp) denote PCR reactions with primer pairs designed to 
different regions of the gene; VNO with bone denotes tissue dissected with the bone 
capsule intact; VNO without bone denotes tissue with the bone removed. GAPDH 
(bottom panel, expected band size of 530 bp) is used as a control for amount of cDNA in 
each reaction. (B) Quantitative RT-PCR of Pde5a expression in each tissue listed, 
normalized to GAPDH. (C-E) Pde5a in situ hybridization in VNO sections showing 
Pde5a expression in endothelial cells and smooth muscle cells of the VNO blood vessel. 
(F-H) PDE5A colormetric antibody staining in VNO sections. C, D, anti-sense probe to 
Pde5a; E, sense probe to Pde5a. H, no antibody staining control. Scale bars, 100 µm (C, 
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We further performed quantitative RT-PCR to assess the relative expression 
levels of Pde5a using RNA extracted from the bladder, VNO, penile tissue and liver.  
Primers to amplify GAPDH were used to normalize the amount of Pde5a to the total 
amount of cDNA template used for each reaction. Compared to tissues with known 
expression of Pde5a, the vomeronasal organ expresses the highest level of Pde5a 
transcript (Figure 2.3B). 
To determine the cellular localization of PDE5A within the VNO, we performed 
in situ hybridization with a Pde5a anti-sense RNA probe and immunohistochemistry with 
an antibody against PDE5A. In situ hybridization showed robust Pde5a staining localized 
to the innermost layers of the blood vessel when the colormetric detection reaction 
wasdeveloped for a short period of time (Figure 2.3C-E), suggesting that Pde5a transcript 
is highly expressed in the endothelial and smooth muscle layers immediately surrounding 
the main blood vessel in the VNO. When the colorimetric reaction for the Pde5a in situ 
was developed longer with its substrate solution (4-5 hours), staining in the outer smooth 
muscle cells of the blood vessel also appeared (Figure 2.3F-H), indicating that Pde5a is 
likely also expressed in these smooth muscle cells, albeit at a lower level than those 
directly surrounding the main blood vessel. Immunohistochemistry with an antibody for 
PDE5A shows a similar pattern of PDE5A protein in endothelial and smooth muscle cells 
(Figure 2.3I-K). It is interesting to speculate about the functions of these different types 
of smooth muscle cells in the VNO cavernous tissue, and how they are regulated by 
PDE5A. Even after the longest development in NBT/BCIP solution (6 hours), no staining 
in the neuroepithelium exceeded any background staining seen in the sense probe control. 
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Fluid entry into the VNO is reduced after local PDE5A inhibitor application 
 The high expression of PDE5A in the VNO blood vessel suggested a potential 
role for PDE5A in regulating the vomeronasal pump. To test this hypothesis, we applied 
PDE5A inhibitors, sildenafil or tadalafil, locally to the VNO and measured the transport 
of fluid into the VNO (Wysocki et al., 1980). 
 Sildenafil and other PDE5A inhibitors have been commercially available for over 
a decade and have been historically used to treat blood vessel-based erectile dysfunction 
in men (Aversa et al., 2006, Ballard et al., 1998, Gresser and Gleiter, 2002, Sommer and 
Schulze, 2005). Their potent vasodilative properties have also facilitated their approval to 
treat pulmonary arterial hypertension (Archer and Michelakis, 2009, Corbin et al., 2005, 
Croom and Curran, 2008, Galie et al., 2005, Hoeper, 2005). Their widespread ability to 
acutely modulate blood vessel tone in many organs led us to propose that sildenafil and 
tadalafil could also be used as tools to inhibit PDE5A in the VNO blood vessel. So, we 
applied PDE5A inhibitors to the VNO and observed any consequences of this treatment.  
 We chose to locally apply PDE5A inhibitors because we found that universal 
administration of sildenafil or tadalafil by intra-peritoneal injection or oral gavage at a 
dose comparable to that of humans (FDA-approved doses) resulted in reduced motion 
and exploratory behavior in many treated mice (data not shown), presumably due to 
widespread vasodilation throughout the body. To locally apply PDE5A inhibitors to the 
VNO, 10 µL of drug solution was applied to the tip of the nose, allowing it to be inhaled 
into the nasal cavity and a portion of it pumped into the VNO.  
 We first confirmed the efficient delivery of the inhibitors into the VNO by 
monitoring fluorescence in the VNO when the drug solution was mixed with a  
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Figure 2.4: Locally inhibiting PDE5A reduces rhodamine dye entry into the 
vomeronasal organ. 
(A) 2X brightfield microscopy of a bisected mouse head showing the general structure 
and location of the VNO in the nasal cavity. (B) 2.5X DS red fluorescence microscopy of 
the same mouse head showing the entry of 8 µM rhodamine 6G dye mixed with sildenafil 
(orange) into the VNO upon application of the solution locally to the tip of the nose. (C) 
Zoomed in brightfield image of a dissected VNO, showing the general morphology of the 
VNO, including the location of the blood vessel (BV). (D) DS red fluorescence in 
dissected VNO tissue (VNO is removed from the nasal cavity) after rhodamine dye 
application. (E-G) DS red fluorescence in intact VNO tissue after treatment with saline 
(E), sildenafil (F), or tadalafil (G). The VNO in each image is outlined in dashed white 
lines. (H) Total dye intensity in the VNO after treatment with sildenafil (red dots) or 
tadalafil (blue dots) normalized to saline-treated controls (black dots) for each trial is 
quantified. Each dot indicates quantified fluorescence from one mouse. Error bars 
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fluorescent dye, rhodamine-6G chloride (8 µM). Mice were killed 5 minutes after the 
drug/dye solution was applied, the head was non-symmetrically bisected, leaving the 
VNO intact, and whole-mount rhodamine fluorescence was imaged using a standard 
fluorescent microscope. Rhodamine fluorescence was seen throughout the VNO (Figure 
2.4B; see brightfield image, Figure 2.4A, to see the location of VNO within the nasal 
cavity). Similar fluorescent dye-based assays have been previously used to monitor the 
delivery of pheromones or fluid to the VNO lumen (Ogura et al., 2010, He et al., 2010, 
Ben-Shaul et al., 2010, Wysocki et al., 1980). No alterations in motion or exploratory 
behavior were observed when PDE5A inhibitors were delivered to the VNO by this 
method.  
 To ensure that the rhodamine dye fluorescence we were seeing was from dye that 
was pumped into the VNO and not just background fluorescence from dye accumulating 
within the nasal cavity, we extracted the VNO from the nasal cavity after rhodamine dye 
administration to the tip of the nose and imaged the dissected tissue. Reassuringly, we see 
fluorescence from the VNO lumen (Figure 2.4D). The VNO blood vessel is located on 
the lateral surfaces of the tissue, so it is still visible when imaging fluorescence (Figure 
2.4D; brightfield, C). 
 Similar fluorescent dye-based assays have been previously used to monitor the 
delivery of pheromones or fluid to the VNO lumen (Ogura et al., 2010, He et al., 2010, 
Ben-Shaul et al., 2010). To test whether PDE5A inhibitors alter the transport of fluid into 
the VNO, sildenafil (30 mM), or tadalafil (5 mM), or saline (control), was applied locally 
to the tip of the nose, and mice were placed into a clean cage for 30 minutes. 10 µL of 
rhodamine-6G dye (8 µM) was then applied to the tip of the nose, and mice were placed 
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into a cage with soiled bedding for 5 minutes. Mice were then killed, rhodamine 
fluorescence was imaged, and the relative fluorescence intensity in the VNO region was 
quantified in ImageJ for each condition.  
 When mice were treated with the saline vehicle, dye readily entered the VNO and 
rhodamine fluorescence was bright when the tissue was imaged (Figure 2.4B, D). In 
contrast, when PDE5A inhibitors, either sildenafil or tadalafil, were applied locally to the 
VNO, 50% less dye entered the VNO lumen (Figure 2.4F, G) when compared to vehicle-
treated controls (quantified in Figure 2.4H). This suggests that the application of PDE5A 
inhibitors locally to the VNO disrupts the VNO pump and that when this pump was 
disrupted substances were not actively transported into the VNO lumen.  
	  
	   42 
DISCUSSION 
 
In this study, we found high expression of PDE5A in the VNO blood vessel in 
mice and showed evidence to support an essential role of PDE5A in vomeronasal pump 
regulation. Our findings show that PDE5A is highly expressed in the inner layer of cells 
directly surrounding the VNO blood vessel, which include both endothelial cells and 
smooth muscle cells. Pharmacologically inhibiting PDE5A in these cells with sildenafil 
or tadalafil attenuated fluid delivery to the VNO. While many studies have implicated the 
importance of the VNO pump for stimulus delivery to the VNO, this study is one of the 
first to demonstrate a potential molecular mechanism for this process.  
In many mammalian species, the detection of odors serves as an important 
mechanism by which animals gain insight about their environment. Pheromones are 
odors that elicit innate conspecific behaviors in many animals (Bind et al., 2013, Beny 
and Kimchi, 2012, Dulac and Torello, 2003, Kashiwayanagi, 2014, Keverne, 2002a, 
Petrulis, 2011). The VNO is known to play an important role in the detection and 
processing of these pheromone cues. The main olfactory system detects odors from the 
environment in a fairly passive way, relying on the diffusion of volatile odor molecules 
into the nasal cavity, where the odors then bind exposed receptors in the mucus. In stark 
contrast, the vomeronasal organ is not equipped to solely rely on passive diffusion – it is 
encapsulated by rigid bony structures, and only a small opening in the nasal cavity serves 
as a channel for pheromones to enter the organ. Animals need to be in direct physical 
contact with a pheromone source in order for pheromones to enter the nasal cavity. All of 
these facts together substantiate the requirement of an active mechanism for pheromone 
delivery to VSNs. 
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Studies have shown that this active delivery is provided by a pumping mechanism 
within the VNO, which draws pheromones from the nasal cavity through the small 
opening, and into the VNO (Meredith, 1994, Meredith et al., 1980, Meredith and 
O'Connell, 1979). While many studies have described the role of the vasculature in the 
regulation of the pumping-based mechanism of pheromone delivery (Salazar and Sanchez 
Quinteiro, 1998, Salazar et al., 2008, Salazar I, 1998), no molecular mechanisms for this 
process have been proposed. 
Dynamic regulation of blood vessel tone is necessary for efficient delivery of 
oxygen and nutrients around the body. In some organs, the vasculature also serves as a 
dynamic system that is specialized to suit the functions of the organ. In the penis, for 
example, sustained dilation of cavernous tissue blood vessels induces and maintains 
erection. In the VNO, cycles of constriction and dilation of the blood vessel serve as a 
pump to draw pheromones into and out of the organ (Meredith and O'Connell, 1979).  
Nitric oxide (NO) signaling and cGMP second messengers have been extensively 
characterized in the regulation of vascular tone in many organs, where NO released from 
vascular endothelial cells or nerve terminals enters smooth muscle cells to stimulate the 
production of cGMP that in turn triggers smooth muscle relaxation and vasodilation 
(Amezcua et al., 1989, Gardiner et al., 1990, Moncada et al., 1991, Palmer et al., 1988, 
Rees et al., 1989). Previous studies have found neuronal nitric oxide synthase (nNOS) 
expression in the VNO blood vessel (Kishimoto et al., 1993, Matsuda et al., 1996, 
Zancanaro et al., 1999, Kulkarni et al., 1994). We also examined the expression of nNOS 
and endothelial NOS (eNOS) in the VNO using immunostaining. We found that nNOS 
staining localized primarily in the smooth muscle layer of the blood vessel, which was 
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consistent with previous studies. We also showed that eNOS staining localized to the 
endothelial cell layer of the blood vessel. A recent study suggested that PDE5A expressed 
in endothelial cells may play a role in reducing protein kinase G (PKG) phosphorylation 
of eNOS, therefore regulating the production of NO in endothelial cells (Gebska MA, 
2011). Further studies are needed to determine the role of endothelial PDE5A in 
regulating VNO blood vessel dynamics.  
PDE5A in the smooth muscle cells degrades cGMP and thus serves as a key 
regulator of vascular tone. Inhibitors of PDE5A have been developed to mediate 
sustained blood vessel dilation and have been used to treat vascular-related conditions 
including erectile dysfunction (Aversa et al., 2006, Sommer and Schulze, 2005, Ballard et 
al., 1998, Aversa et al., 2007) and pulmonary hypertension in humans (Baliga et al., 
2008, van Driel, 2006, Corbin et al., 2005, Hoeper, 2005, Pabani and Mousa, 2012). Our 
results support an essential role of PDE5A in regulating the vomeronasal pump. 
Intriguingly, we also observe robust PDE5A expression in the endothelial cells of the 
blood vessel. PDE5A expression has been reported in endothelial cells (Morelli et al., 
2004, Gebska MA, 2011), but most studies and therapeutics target PDE5A in smooth 
muscle cells. The high level of PDE5A we see in endothelial cells suggests that 
endothelial PDE5A may also regulate VNO blood vessel dynamics through an unknown 
mechanism.  
While PDE5A in smooth muscle cells is used to regulate sustained vascular tone 
in many organs, PDE5A also in the endothelial cells of the VNO blood vessel might be 
optimal for regulating the rapid cycling of constriction and dilation needed for pump 
function. PDE5A in both cell types may acutely regulate VNO blood vessel dynamics so 
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that the animal is able to efficiently sample pheromones from its environment. Our data 
suggests that treatment with PDE5A inhibitors disrupts local regulation of blood vessel 
dynamics, therefore abolishing VNO pump activity.  
 Although this study predominantly focused upon elucidating the molecular 
mechanisms of the VNO pump in mice, I have provided an effective way to acutely and 
reversibly attenuate VNO function in vivo. Previously, surgical removal of the VNO 
(Beauchamp et al., 1982, Pankevich et al., 2004) or genetic manipulation (Stowers et al., 
2002) were the main ways to disrupt the function of the system. With the use of PDE5A 
inhibitors, we are now able to acutely attenuate pheromone delivery in animals in vivo 
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METHODS 
 
Chemicals used for this study: 
 
Sildenafil citrate salt (Sigma-Aldrich #PZ0003) 1-3-(4,7-Dihydro-1-methyl-7-oxo-3-
propyl-1H-pyrazolo4,3-dpyrimidin-5-yl)-4-ethoxyphenylsulfonyl-4-methylpiperazine 
citrate salt, 5-2-Ethoxy-5-(4-methylpiperazin-1-yl)sulfonylphenyl-1-methyl-3-propyl-4H-
pyrazolo5,4-epyrimidin-7-one citrate salt 
Tadalafil (Sigma-Aldrich #Y0001417) 
Rhodamine 6G-chloride (Sigma-Aldrich #R634)  
Denatonium benzoate (Sigma-Aldrich #D5765) 
2,2 Tribromoethanol (Avertin, Sigma-Aldrich, St. Louis, MO) 
Reverse Transcription: Adult mice (>2 months of age) were intraperitoneally injected 
with 250 mg/kg body weight Avertin (Sigma) and all organs (vomeronasal organ, liver, 
eye, heart, corpus cavernosum and bladder) were immediately dissected and 
homogenized in TriZol (Life Technologies). RNA was extracted using phenol-
chloroform. Primer sets were designed to recognize all splice variants of PDE5A. RT 
reactions were run with 0.5 µg of total RNA for all reactions. Amplification for GAPDH 
was used as a reaction control for each tissue.  
Primers for Pde5a (predicted sizes: 767 bp and 711 bp): 
SET #1: CGGCCTACCTGGCATTCTG; GCAAGGTCAAGTAACACCTGATT 
SET #2: AAGGCATCCGAGCCCATAC; TGGGTCTAAGAGGTCGGTCAA 
Primers for Gapdh (predicted size: 530 bp): 
AGGCCGGTGCTGAGTATGTC; TGCCTGCTTCACCACCTTCT 
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Primers for nNOS (predicted size: 307 bp): 
CTGTGACAACTCTCGATACAACATC; GAGTCTATAGTTGAGCATCTCCTGG 
Primers for eNOS (predicted size: 515 bp): 
ACACTGCTAGAGGTGCTGGAGCAAT; GGATCCCTGGAAAAGGCGGTGAGG 
Primers for iNOS (predicted size: 331 bp): 
CCCTTCCGAAGTTTCTGGCAGCAGC; GCTTCTTCAATGTGGTAGCCACATC 
 
Real-Time quantitative RT-PCR for PDE5A: 
Whole VNO, bladder, penile and liver tissue were collected, lysed in TriZol™ reagent 
(Invitrogen) and total RNA was extracted and purified with phenol-chloroform. RNA was 
reverse transcribed using a RETROscript™ kit (Ambion). Quantitative RT-PCR was 
performed using SYBR green master mix (BioRad) with a BioRad iCycler instrument. 
Relative transcript levels were calculated using 2-∆∆ Ct method Schmittgen TD, 2008, 
normalizing to GAPDH transcript as an internal control between samples. 
Primers for Pde5a: 
SET #1: CGGCCTACCTGGCATTCTG; GCAAGGTCAAGTAACACCTGATT 
SET #3: AAGGCATCCGAGCCCATAC; TGGGTCTAAGAGGTCGGTCAA 
Primers for Gapdh : 
CCTGCACCACC AACTGCTTA; CCACGATGCCAAAGTTGTCA 
 
 
Tissue Preparation for in situ hybridization/immunohistochemistry: Mice were 
anesthetized using Avertin (250mg/kg body weight), transcardially perfused with 0.1 M 
phosphate buffered saline (PBS), followed by 4% paraformaldehyde (PFA) buffered in 
PBS. Tissue was post-fixed for 1 hour, and then decalcified in 10% 
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ethylenediaminetetraacetic acid (EDTA) for 3-4 days. Tissue was cryo-protected in 30% 
sucrose (Sigma-Aldrich, St. Louis MO) dissolved in PBS overnight (approximately 12-16 
hours). Tissue was embedded with OCT (Sakura Finetek), and 14 µm coronal sections of 
the VNO were collected Slides were stored at -80°C until use. 
Immunohistochemistry: Sections were rehydrated in 0.1M PBS for 10 minutes at room 
temperature and permeabilized in 0.1-1% Triton-X-100 for 10 minutes. Slides blocked in 
5% goat serum (in 0.1% Triton-X-100/0.1M PBS buffer). Primary antibodies were 
diluted in blocking buffer (see table) and incubated on tissue overnight at 4°C. Alexa-
Fluor-conjugated secondary antibodies were incubated on tissue for 1-2 hours at room 
temperature. Slides were mounted with Fluoromount (Sigma-Aldrich, St. Louis, MO) 
with DAPI (1:1000) and visualized with confocal (LSM 510/confocor, Zeiss) 
microscopy. 
For colormetric immunohistochemistry, all procedures prior to secondary antibody 
application were identical to those used for fluorescent immunohistochemistry. After 
incubation in primary antibody overnight, slides were washed and treated with a 
Vectastain ABC reagent kit (Vector Laboratories), using a secondary antibody that is 
conjugated to biotin with a streptavidin amplification system. Colormetric  
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Antibodies used for Immunohistochemistry: 
Antibody Species Dilution Ordering Info 
Smooth muscle actin (SMA) Mouse IgG2a 1:250 Sigma-Aldrich #A2547 
CD31 (PECAM) Rat 1:500 BD Biosciences  #550274 
Tyrosine Hydroxylase (TH) Rabbit 1:500 Millipore  #AB152 
nNOS Goat 1:2000 Abcam  #AB1376 
eNOS Rabbit 1:500 Santa Cruz  #sc-654 
NPY Rabbit 1:500 Peninsula Labs T-4070 
ChAT Mouse 1:200 NeuroMAB 75-020 
GAD65 Rabbit 1:1000 Abcam #ab49832 
5-HT Goat 1:500 Immunostar #20079 
 
In situ hybridization: All methods described were modified from Ishii et al., 2004. 
Riboprobe templates for phosphodiesterase 5A (PDE5A) were created using cDNA from 
isolated VNO. Templates were cloned into TOPO-TA vector (Thermo-Fisher, Waltham, 
MA). Plasmids were then linearized using BamHI and XbaI restriction enzymes (New 
England Biolabs, Ipswich, MA). Linearized plasmids were phenol-chloroform purified 
for in vitro transcription reactions. BamHI-cut inserts were transcribed with T7 RNA 
polymerase (Invitrogen, Grand Island, NY) and XbaI-cut inserts were transcribed with 
Sp6 RNA polymerase (Ambion, Grand Island, NY).  
All solutions used prior to probe hybridization were treated with diethylpyrocarbonate 
(DEPC) (Sigma-Aldrich, St. Louis, MO). VNO cryosections were post-fixed in 4% 
paraformaldehyde for 15 minutes at room temperature and washed in 0.1M PBS/DEPC. 
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Tissue was digested with Proteinase K (10ug/mL in Tris buffer) for 10 minutes at 37°C 
and post-fixed in 4% PFA for 10 minutes at room temperature. Slides were washed in 
0.1M PBS/DEPC and incubated in 0.2N HCl for 20 minutes. Slides were acetylated in 
acetic anhydride/triethanolamine (acetylation buffer) and dehydrated subsequently in 
60%, 80%, 95%, 100% and 100% ethanol. Samples were air-dried for 10 minutes and 
equilibrated in Hybridization Buffer for 1 hour at room temperature in a humid chamber. 
Probes were diluted in Hybridization Buffer (0.1-0.3 µg/100 µL) and heated at 85°C for 3 
minutes to prevent secondary structure formation. 100 µL of probe/hybridization buffer 
was applied to coverslips and slides were inverted and placed face down onto coverslips. 
Probes were hybridized for 12-16 hours in a humid chamber set to 65°C. Following 
overnight hybridization, coverslips were removed from slides and washed in 2XSSC/50% 
formamide for 30 minutes at 55°C and then in 0.2X SSC (x3) at 55°C. Slides were 
equilibrated in 10% donkey serum block (TNB buffer) for 1 hour at room temperature in 
a humidified chamber. Anti-DIG-AP Fab Fragment antibody (Invitrogen, Grand Island, 
NY) was diluted 1:5000 in TNB buffer and 200 µL of antibody/TNB buffer was applied 
to each slide, covered with strips of parafilm and incubated at 4°C overnight. After 12-16 
hours, slides were washed in TN buffer and then equilibrated in a magnesium-based 
buffer for 10 minutes at room temperature. 1 NBT/BCIP tablet (Roche) was dissolved in 
10 mL distilled water and precipitate was removed using a sterile filter. Solution was 
generously applied to slides and slides were kept in the dark for 2-6 hours and monitored 
intermittently for alkaline phosphate colormetric precipitate, using sense-treated slides as 
a control. Slides were then washed in 0.1M PBS and sterile water and cover-slipped with 
Fluoromount aqueous mounting medium (Sigma-Aldrich, St. Louis, MO). 
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Primers used to make Pde5a anti-sense probe sequence (predicted size: 766 bp):  
CCAAGCAGATGGTGACATTAGA; CCAGGGTTTAGTAATCGCAGAG 
 
Rhodamine Dye Test: Adult male and female mice (age > 3 months) were used for this 
assay. Sildenafil citrate (Sigma-Aldrich, St. Louis, MO) and tadalafil citrate (Sigma-
Aldrich, St. Louis, MO) were dissolved in sterile 0.9% NaCl and 10 µL of sildenafil 
citrate, tadalafil citrate or sterile saline (control) was applied directly to the tip of the 
nose. Final concentration of sildenafil citrate administered to each mouse was 30 mM and 
tadalafil citrate at a concentration of 5 mM. Mice were single-housed in a clean cage after 
drug/saline application for 30-45 minutes. 10 µL of rhodamine dye (8 µM diluted in 
sterile saline, Sigma-Aldrich, St. Louis, MO) was applied directly to the tip of the nose 
and mice were placed in a stimulation cage (soiled bedding cage from adult mice of the 
opposite gender) for 5 minutes. Mice were decapitated and heads were bisected, exposing 
the VNO. All images were taken at the same exposure on each day. Fluorescence 
intensity in the VNO was quantified from images using ImageJ software 
(http://rsb.info.nih.gov/ij/, National Institutes of Health, Bethesda, MD). The VNO in 
each image was selected as the region of interest for all measurements. The threshold for 
fluorescence intensity measurements was set with the first saline-treated control mouse 
and the same threshold was used for all fluorescence measurements from that day. 
Fluorescence intensity was measured in arbitrary units (with saline-treated control values 
set to 100). 
 
Statistical analyses: Statistical analyses were all performed with GraphPad Prism 
software. All Student’s t tests were performed assuming Gaussian distribution, two-tailed, 
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unpaired, and a 95% confidence interval. One-way or two-way ANOVA was used for 
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ABSTRACT 
 The findings in Chapter 2 of this dissertation describe a potential molecular 
signaling pathway responsible for regulating pheromone transport to VSNs in the VNO. 
Although the robust expression of PDE5A in the VNO blood vessel and the well-
characterized functions of PDE5A in other organs strongly suggest the importance of 
PDE5A activity for controlling VNO vascular dynamics, it is necessary to test and 
determine the consequences of blocking this enzyme in order to decipher its role and 
necessity in this system. One way to evaluate the importance of PDE5A function in 
controlling the VNO pump and pheromone delivery to the VSNs is through the 
visualization of VSN activity in response to pheromones. Although there are several 
ways to analyze VSN response to pheromone cues, one straight-forward method is 
through monitoring the induction of established neuronal activity markers. In this 
chapter, I characterized pheromone-induced VSN expression of some classical activity 
markers commonly used in different types of neurons throughout the brain, as well as 
some markers that have been shown to report odor-induced OSN activation. We found 
that the phosphorylation of ribosomal protein S6 (pS6) can be used as an acute 
pheromone-induced VSN activity marker, and that treatment with PDE5A inhibitors prior 
to pheromone stimulation decreases pS6 levels in VSNs, supporting the notion that 
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INTRODUCTION 
 Sensory neurons detect cues from the environment and transmit information to the 
brain so that an animal is able to respond to external stimuli. Although neuronal circuits 
and different cell types may exhibit varying degrees of responses to a given cue, many of 
them undergo a signaling pathway initiated by the stimulus, which eventually leads to the 
depolarization or hyperpolarization of the neuron. This activated neuron then propagates 
this signal to other areas of the brain to elicit an appropriate response. Sensory neurons in 
the vomeronasal system, or VSNs, detect pheromones from the environment, where the 
binding of a pheromone to its cognate receptor on a VSN activates the opening of various 
ion channels, initiating signaling cascades within the neuron, and eliciting changes in 
gene expression (Francia et al., 2014, Munger et al., 2009, Dulac and Torello, 2003). 
 Although the induction or repression of certain genes can vary from neuron to 
neuron, some transcripts have been analyzed and seen in multiple types of neurons in 
response to a stimulus. These genes are referred to as immediate early genes (Hoffman et 
al., 1993), since they have been shown to be early indicators of neuronal activation 
(Kovacs, 2008). Among these, the classical immediate early gene markers, cfos (a proto-
oncogene) and egr1 (early growth response 1), have been commonly used in multiple 
neuronal systems. Use of these classical immediate early genes has been implemented in 
sensory neurons, and these genes are commonly used as markers of VSN or accessory 
olfactory bulb (AOB) neuronal activity (Honda et al., 2008, Inamura and Kashiwayanagi, 
2000, Inamura et al., 1999, Kimoto and Touhara, 2005, Matsuoka et al., 1999, Tubbiola 
and Wysocki, 1997). Based upon these reports, many activity markers could potentially 
be used to report VSN activation in response to pheromones.  
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 The rhodamine dye data mentioned in Chapter 2 supports the notion that 
inhibition of PDE5A disrupts the VNO pump, which results in less fluid, and presumably, 
fewer pheromones, being pumped into the VNO lumen. If so, the VSN response to 
pheromones should be reduced after inhibitor treatment since the pheromones will not be 
in proximity to VSN receptors. To further test whether the reduced fluid entry into the 
VNO lumen that we see after inhibitor treatment has a functional consequence in the 
VSNs, we wanted to use neuronal activity markers to assess VSN activation upon 
pheromone exposure with or without the application of PDE5A inhibitors to the VNO. 
The utilization of this method would allow us to determine whether PDE5A inhibitors 
attenuate the VNO pump to a degree that prevents pheromones from entering the VNO 
lumen and activating VSNs.  
 To determine which activity marker would best suit our needs, we performed a 
comprehensive survey of many of these markers in VSNs. To survey stimulation of 
immediate early gene markers and determine general VSN response to pheromone 
stimulation, we exposed mice to soiled bedding from the opposite gender mouse for 30-
60 minutes, collected VNO tissue, and examined a panel of activity markers in VSNs in 
response to pheromone stimulation.  
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RESULTS 
 
The classical activity markers, egr1 and cfos exhibit no expression in VSNs after 
pheromone exposure  
 The Dulac lab has shown robust egr1 induction in VSNs after 30 minutes of 
pheromone exposure, and that the induction of this gene greatly exceeded expression of 
other classical activity markers (Isogai et al., 2011). Other laboratories have also utilized 
the expression of this gene/protein as an indicator of neuronal activity in the vomeronasal 
system (Brennan et al., 1999, Haga-Yamanaka and Touhara, 2013). The Cherry and 
Baum labs have frequently used cfos to report VSN and AOB neuron activity (Halem et 
al., 1999, Halem et al., 2001b, Pankevich et al., 2003, Pankevich et al., 2006). Both of 
these markers (transcript and/or protein), have been commonly used in many fields to 
report neuronal activity, thus we decided to investigate these markers for use in our 
system.   
 To first obtain an overall global indication showing whether egr1 and cfos 
expression are induced upon pheromone exposure, we extracted total RNA from VNO 
tissue from mice exposed to pheromones as described above and performed quantitative 
RT-PCR to compare levels of egr1 and cfos between pheromone-exposed (stimulated) 
mice and unexposed (unstimulated) controls. Since VNO tissue contains cells other than 
VSNs, we tried to control for the number of VSNs within each sample by normalizing 
egr1 and cfos transcript levels to trpc2, a VSN signal transduction component. 
Pheromone stimulation only modestly increased cfos expression when compared to 
unstimulated controls (Figure 3.1A, black bars) and no difference was seen in egr1 
transcript levels (Figure 3.1A, white bars).  
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Figure 3.1: Classical immediate early genes egr1 and cfos cannot be used to detect 
pheromone-induced vomeronasal sensory neuron activation. 
(A) Quantitative RT-PCR of VNO tissue treated with saline or sildenafil with and 
without pheromone exposure. Egr1 and cfos were not significantly upregulated upon 
pheromone stimulation, and sildenafil treatment had no effect on expression of 
transcripts. (B-D) VSN expression of egr1 was not induced upon pheromone stimulation, 
via in situ hybridization (C) or Egr1 antibody staining (D) compared to unstimulated 
controls (B). (E-J) As positive controls for Egr1 in situ hybridization and Egr1 antibody 
staining, olfactory epithelium (E, F) and olfactory bulb (G-N) from unstimulated (G, I, K, 
M) and pheromone exposed (E, F, H, J) or odor-exposed (L, N) mice were stained. 
Sections from pheromone or odor-exposed mice showed robust induction of Egr1 
transcript (E, F, L) and Egr1 protein (H, J, N) compared to unstimulated controls (G, I, K, 
M). (O-P) VNO sections were also analyzed for pheromone-induced cfos (P), compared 
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 We further performed in situ hybridization on VNO tissue sections, and under our 
laboratory conditions, did not visualize any egr1 or cfos signal via immunohistochemistry 
or in situ hybridization (Figure 3.1B-D), even though we saw positive staining in OSNs 
from olfactory epithelium that was present in the same tissue sections (Figure 3.1E, F). 
We also performed immuno-blotting with Egr1 and c-fos antibodies in 
unstimulated/stimulated VNO tissue and again, saw no difference in expression of either 
protein between the two groups (data not shown). 
 Along with obtaining VNO sections from unstimulated and stimulated animals, 
we also collected sections of AOB and OB from these animals and immunostained them 
for Egr1 and c-fos. Interestingly, we saw a strong induction of Egr1 protein in the main 
olfactory bulb of mice exposed to pheromones (Figure 3.1H, green; J, gray) compared to 
unstimulated controls (Figure 3.1G, I), but no obvious differences were seen in the AOB 
of these mice under these conditions. 
 To ensure that our staining protocols were capable of detecting activated neurons, 
we performed odor-induced stimulation of OSNs, and assayed for egr1 expression in the 
olfactory bulb. We saw robust induction of egr1 mRNA and Egr1 protein in neurons in 
the olfactory bulb upon a 45 minute-odor stimulation (Figure 3.1L, N) compared to 
unstimulated non-odor exposed controls (Figure 3.1K, M), consistent with previous 
reports that show olfactory bulb neurons exhibit high levels of egr1 induction upon odor 
stimulation (Kress and Wullimann, 2012, Akiba et al., 2009). Similar results were seen 
when we analyzed cfos expression (Figure 3.1O, P). Although modest induction of cfos 
occurred in the VNO tissue via qRT-PCR after pheromone exposure, no obvious staining 
was seen in VSNs via immunohistochemistry or in situ hybridization between stimulated 
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(Figure 3.1O) and unstimulated (Figure 3.1P) controls in our experiments, in contrast to 
the strong induction of cfos observed with in situ hybridization in the olfactory bulb after 
odor exposure (data not shown).  
 Together, the classical activity markers, egr1 and cfos exhibited no expression in 
VSNs after pheromone exposure under our assay conditions.  
 
OSN-specific activity markers cannot be used to assay for VSN activation 
 The Reed lab has demonstrated the induction of Lrrc3b (leucine-rich repeat 
containing 3b) in OSNs after odor exposure (Bennett et al., 2010, Tadenev et al., 2011). 
Screens identifying markers up-regulated in stimulated OSNs have also listed Lrrc3b in 
activated OSNs (Fischl et al., 2014). Instead of analyzing whole VNO tissue for 
transcripts expressed upon stimulation (since these methods may not be sensitive enough 
to differentiate activity marker expression changes specifically in subsets of VSNs), we 
chose to use in situ hybridization to observe any changes for Lrrc3b expression in VSNs. 
Again, we saw no expression in VSNs within our laboratory setting using our stimulation 
paradigms (Figure 3.2A, B).  
 The same screens and reports showing Lrrc3b expression in OSNs also describe 
S100a5 transcript changes in OSNs upon odor exposure (Bennett et al., 2010, Fischl et 
al., 2014, Tadenev et al., 2011), so we also performed in situ hybridization for S100a5 
transcripts in VNO sections. Encouragingly, we saw induction of S100a5 in a small 
subset of VSNs after a 30-minute exposure to pheromones (Figure 3.2D, arrows), and no 
staining in unstimulated controls (Figure 3.2C), or in sense-treated stimulated sections 
(data not shown). However, this expression was only induced in a few VSNs, contrary to  
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Figure 3.2: OSN activity markers, Lrrc3b or S100a5 cannot be used to detect 
pheromone-induced vomeronasal sensory neuron activation. 
(A-B) 30 minutes of pheromone exposure does not induce Lrrc3b (B) expression 
compared to unstimulated controls (A). (C-D) A few VSNs exhibit S100a5 transcript 
expression (D) compared to unstimulated controls (C).  (E-G) As a control example, 
S100a5 expression in OE sections from mice exposed to odor (F) were compared to 
unstimulated OE controls (E), and odor-stimulated tissue with sense S100a5 probe (G). 
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the robust staining we see in OSNs from OE sections after odor exposure (Figure 3.2E-
G).  
 
A novel neuronal activity marker, pS6, is up-regulated in VSNs after exposure to 
pheromones  
 Recently, the Friedman lab showed that the phosphorylation of the ribosomal 
protein S6 could also be used as a marker of neuronal activity (Knight et al., 2012). S6 is 
a component of the ribosome that is phosphorylated downstream of many signaling 
cascades, including the PKA, MAPK, and PI3K/mTOR pathways (Meyuhas, 2008, 
Valjent et al., 2011), which are also upstream pathways in the transcription of cfos 
(Flavell and Greenberg, 2008). Phosphorylation of S6 is also now being used in the 
olfactory system to identify the molecular profiles of OSNs that respond to specific odors 
(Jiang et al., 2015). Phosphorylated S6 (pS6) has been reported to be induced along the 
same time scale as other immediate early genes, and this expression is seen 
approximately ten minutes to two hours after stimulation (Knight et al., 2012). For our 
purposes, this was suitable.  
 We conducted immunostaining with two antibodies for pS6. Very little pS6 
staining was observed in unstimulated controls (Figure 3.3A), but upon pheromone 
exposure, robust pS6 staining was seen in VSNs (Figure 3.3B, quantified in Figure 3.3C). 
We saw robust pS6 expression in VSNs after varying durations of stimulation. After 
repeatedly confirming this pattern of pS6 expression in VSNs, we decided to utilize this 
method to visualize VSN activation in response to pheromones with and without local 
inhibitor treatment.  
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Figure 3.3: Phosphorylation of ribosomal protein S6 is increased via 
immunohistochemistry upon pheromone stimulation and is reduced after treatment 
with PDE5A inhibitors. 
(A-C) The phosphorylation of ribosomal protein S6 (green) is increased upon pheromone 
stimulation (B) when compared to unstimulated controls (A) using antibodies specific to 
the phosphorylation sites 235/236 and 240/244 of ribosomal protein S6. Quantified in 
(C). Each dot indicates the average number of pS6-positive cells per 0.2 mm2 of VNO 
from one mouse. Averages were obtained from cell counts from 6-9 coronal VNO 
sections from each animal. (F-G) Treatment with PDE5A inhibitors, sildenafil (F) and 
tadalafil (G), prior to pheromone stimulation results in diminished pS6 staining compared 
to saline-treated animals (E) and is similar to unstimulated controls (D). (H) 
Quantification of the average number of pS6-positive cells per 0.2 mm2 of VNO 
neuroepithelium. Each dot indicates the average number of pS6-positive cells per 0.2 
mm2 of VNO from one mouse. Averages were obtained from cell counts from 6-9 coronal 
VNO sections from each animal. Error bars indicate SEM; Scale bar, A, 100 µm; D, 25 
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 The PDE5A inhibitors, sildenafil (30 mM) or tadalafil (5 mM), or saline vehicle 
was applied locally to the tip of the nose, and mice were placed in a clean cage for 30 
minutes. The mouse was then transferred to a cage containing soiled bedding (pheromone 
stimulated) or clean bedding (unstimulated) for 30 minutes, and then the VNO tissue was 
collected and sectioned for pS6 immunohistochemistry. Few pS6-positive cells were 
observed in the vomeronasal epithelium of saline-treated mice exposed to clean bedding 
(Figure 3.3D), whereas many pS6-positive cells were observed when saline-treated mice 
were exposed to the soiled bedding (Figure 3.3E; quantified in Figure 3.3H). Sildenafil or 
tadalafil treatment resulted in approximately 75% fewer pS6-positive cells in the 
vomeronasal epithelium of mice exposed to pheromones (Figure 3.3F, G). No difference 
was observed between inhibitor-treated mice and saline-treated mice when they were 
exposed to clean bedding, potentially implicating that PDE5A inhibitors had no effect on 
baseline pS6 levels in VSNs (Figure 3.3H). Together, these data are consistent with the 
idea that inhibiting PDE5A in the VNO disrupts the VNO pump, which results in fewer 
pheromones entering the VNO and reduced pheromone detection in the animal.  
  
pS6 expression in the accessory olfactory bulb does not change upon pheromone 
exposure  
 The olfactory field commonly analyzes responses to pheromones by measuring 
activity in the AOB, which is the brain region VSNs innervate to potentiate electrical 
signals to appropriate regions of the brain for further processing (Halem et al., 2001a, 
Pankevich et al., 2003, Veyrac et al., 2011). The AOB is located at the medial-dorsal-
most region of the olfactory bulb (Figure 3.4A, sagittal view) and shows a similar layered  
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Figure 3.4: The phosphorylation of ribosomal protein S6 in response to pheromone 
stimulation cannot be analyzed via immunohistochemistry in the accessory olfactory 
bulb or western blot with whole VNO tissue. 
(A) Schematic of the main and accessory olfactory bulb structure, showing a sagittal view 
of the OB and the location of the AOB in these sections. (B) Schematic of the AOB, 
tilted to show the orientation of the AOB for the images. The diagram shows the layers of 
cells located in the AOB (gl, glomerular layer; mi, mitral cell layer; gr, granule cell 
layer). (C-D) pS6 immunostaining (gray) in sagittal sections of AOB from unstimulated 
mice (C) and mice exposed to pheromones for 30 minutes (D). (E) Western blot using 
protein from unstimulated VNO tissue, 10 min, 20 min, and 45 min pheromone 
stimulation. pS6 240/244, S6, and OMP antibodies were used. (F) Quantification of (E), 
showing that the difference in pS6 expression seen with immunofluorescence cannot be 
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organization as the main olfactory bulb, dividing the AOB into regions such as the 
glomerular layer (gl), the mitral cell layer (mi), the granule cell layer (gr) and the anterior 
commissure (aco) (Figure 3.4A, B). Most neuronal activity markers labeled activated 
cells in the mitral cell layer (MCL) of either the OB or AOB after stimulation.  
 When we exposed mice to pheromones for 30-60 minutes, sectioned the AOB, 
and stained for pS6, we saw dense pS6 labeling of neurons in the mitral cell layer of the 
AOB (Figure 3.4D, gray), but saw no significant difference between the AOBs of 
stimulated (Figure 3.4D) and unstimulated mice (mice not exposed to pheromones; 
Figure 3.4C). 
 We also attempted to analyze pS6 expression in the VNO via Western Blot 
detection; however, when whole VNO tissue was dissected and the same pS6 antibodies 
were used for immunoblotting, no obvious differences were seen between unstimulated 
controls (Figure 3.4E, first 2 lanes, top panel) and pheromone stimulated mice (Figure 
3.4E, lanes 3-5, top panel; quantified in Figure 3.4F). Non-phosphorylated S6 (middle 
panel) and olfactory marker protein (OMP, bottom panel) were used to control for the 
amount of total S6 protein in each sample and to approximate the amount of VSNs within 
each tissue. When we performed immunostaining with the pS6 antibodies, we noticed 
that pS6-positive cells were also seen in regions other than the neuroepithelium. 
Therefore, there could be many populations of cells in the whole VNO tissue that express 
pS6 regardless of pheromone stimulation, and the lack of differences we see in 
immunoblots could be explained from high pS6 expression in regions other than the 
VSNs. The difference in VSN expression of pS6 may not be detectable at this level of 
whole VNO tissue analysis. 
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The effect of lower doses of PDE5A inhibitors on pS6 expression in VSNs  
 No previous studies have reported the expression of PDE5A in the VNO or the 
olfactory system in general, nor have any PDE5A inhibitors been analyzed in the VNO. 
The oral dose for humans comes in 25 mg, 50 mg, or 100 mg capsules. The previously 
reported doses used for mice were between 1 mg/kg body weight to 10 mg/kg body 
weight (Baratti and Boccia, 1999, Boccia et al., 2011, Dadomo et al., 2013, Dadomo et 
al., 2011, Hotchkiss et al., 2005), and some reported as high as 40 mg/kg body weight 
(Balarini et al., 2013), all of which were used in contexts other than the one we were 
examining. Therefore, we wanted to use a similar dose when we administered sildenafil 
locally to the nostril. The previous dose we used for all of our experiments was relatively 
high, 30 mM for sildenafil and 5 mM for tadalafil. To ensure the results we were seeing 
in our assays were likely resulting from the inhibition of PDE5A by the drugs themselves 
and not an alternative side-effect of drug delivery, we wanted to test lower doses of the 
drugs and observe the effects. 
 We tested the drugs at 300 µM for sildenafil and 100 µM for tadalafil. We 
observed similar results that are comparable to the higher dose used in previous assays. 
Saline treatment followed by pheromone exposure results in induction of pS6-positive 
VSNs (Figure 3.5A, black dots), and treatment with 300 µM sildenafil (Figure 3.5A, red 
dots) or 100 µM tadalafil (Figure 3.5A, blue dots) resulted in a marked reduction in pS6 
expression in VSNs after pheromone exposure.  
 When we further decrease those doses 100-fold (3 µM for sildenafil and 1 µM for 
tadalafil), all treatment groups (saline, Figure 3.5B; sildenafil, Figure 3.5C; tadalafil,  
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Figure 3.5: The effect of lower doses of PDE5A inhibitors in pS6 expression in VSNs 





(A) Quantification of phosphorylated S6-positive VSNs from VNO cryosections of mice 
after pheromone exposure (stimulated) after saline (black dots), 300 µM sildenafil (red 
dots), or 100 µM tadalafil (blue dots) treatment. (B) Example images of pS6-positive 
VSNs (green) from VNO cryosections of mice after pheromone exposure (stimulated) 
after saline (B), 3 µM sildenafil (C), or 1µM tadalafil (D) treatment. 
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Figure 3.5D) exhibit a similar number of pS6-expressing VSNs after pheromone 
exposure. Taken together, these results suggest that the critical dose of PDE5A inhibitor 
that disrupts VNO pump activity occurs at a concentration between 3 µM - 300 µM 
(sildenafil) and 1 µM - 100 µM (tadalafil), and validates that the phenotype we saw likely 
resulted from the inhibition via the drugs themselves, rather than from an overall aversive 
effect of a high drug concentration. Although we have identified suitable drug 
concentrations for our purposes, optimizing the dosages will require more rigorous 
studies with both varying concentrations and assays.  
 
Female mice exhibit a variable level of induction of pS6 expression in VSNs upon 
pheromone exposure, whereas male mice exhibit a more consistent pattern of 
induction 
 For the pheromone-induced pS6 expression in VSNs we used both male and 
female mice, exposing them to soiled bedding from the cages of mice of the opposite 
gender. Although the results from this data were analyzed and plotted together as a whole 
(Figure 3.3), we also noticed some variability in pS6-positive VSNs in VNO sections 
from our saline-treated, pheromone-exposed mice. As with any type of stimulation, every 
animal may exhibit a different response to a stimulus. It has been reported that the 
vomeronasal pathways of the brain exhibit sexual dimorphism (Segovia and Guillamon, 
1993), so we chose to analyze if there were any dimorphic effects seen in pS6-positive 
expression after pheromone exposure by analyzing pS6 counts by gender. 
 Saline-treated adult male mice exposed to female soiled bedding displayed robust 
pS6 expression in VSNs, and this result was fairly consistent between different  
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Figure 3.6: Female mice exhibit a variable level of induction of pS6 expression in 
VSNs upon pheromone exposure, whereas male mice exhibit a more consistent 







(A) Quantification of phosphorylated S6-positive vomeronasal sensory neurons in male 
mouse VNO sections in response to no pheromone exposure (unstimulated) or female 
pheromone soiled bedding exposure (stimulated) after saline (black dots), sildenafil (red 
dots), or tadalafil (blue dots) treatment. After saline treatment, pheromone exposure 
induces robust phosphorylation of S6 in VSNs and the number of pS6-positive VSNs is 
reduced after sildenafil or tadalafil treatment. (B) Quantification of phosphorylated S6-
positive vomeronasal sensory neurons in female mouse VNO sections in response to no 
pheromone exposure (unstimulated) or male pheromone soiled bedding exposure 
(stimulated) after saline (black dots), sildenafil (red dots), or tadalafil (blue dots) 
treatment. After saline treatment, pheromone exposure induces a less-pronounced 
increase in pS6 in VSNs. 
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stimulation trials (Figure 3.6A, black dots). Treatment with sildenafil (red dots) or 
tadalafil (blue dots) prior to pheromone stimulation markedly reduced the pS6 expression 
to levels comparable to all unstimulated control groups. 
 When we exposed adult female mice to soiled male mouse bedding after saline 
treatment, we saw a more variable level of pS6 induction in VSNs across different female 
mice and different trials (Figure 3.6B, black dots). A few female mice had pS6 levels 
comparable to unstimulated controls. This observation could have many explanations. It 
could suggest dimorphic responses of male and female mice to pheromones. Many 
studies have shown dimorphic areas of the brain responsible for the processing of 
pheromone detection, so there could be many reasons this phenomenon is occurring, and 
potential explanations are addressed further in the Discussion section. 
 
Phosphorylation of CREB decreases in VSNs after exposure to pheromones 
 Another common marker used to assess stimulation-induced activity of neurons is 
by monitoring the phosphorylation of the transcription factor CREB (cAMP response 
element binding protein). Under normal conditions, CREB is not bound to DNA, but 
upon stimulation, CREB becomes phosphorylated and binds to CRE (cAMP response 
element), where it then recruits CBP (CREB-binding protein) to initiate or repress 
transcription. CREB activity has never been reported in VSNs, so we wanted to see if 
pheromone stimulation induced any changes in pCREB expression in VSNs. 
 We found robust pCREB staining in VSNs with no pheromone exposure 
(unstimulated; Figure 3.7A). Upon a 30-minute pheromone stimulation, we see a 
dramatic decrease in pCREB expression via immunostaining (Figure 3.7B), quantified in 
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Figure 3.7: Phosphorylated CREB decreases in VSNs after exposure to pheromones 
and exhibits a unique pattern of expression. 
(A) Coronal section of VNO showing the phosphorylation of CREB (pCREB) in VSNs 
of unstimulated (no pheromone exposure) mice. (B) Coronal section of VNO showing the 
decrease in pCREB in VSNs after mice were exposed to pheromones. (C) Quantification 
of pCREB-positive VSNs after saline (black) or sildenafil (red) treatment and stimulation 
parameter. (D-E) Schematics showing the VNO as a cylindrical tube, where sections can 
be taken advancing from caudal to rostral (Salazar I, 1998) (D). Schematic of the various 
sections of the VNO as it is sectioned from caudal (left) advancing to rostral (right), and 
the location and structure of the neuroepithelium and blood vessel in these various 
sections (E). (F-G) pCREB staining in a coronal section of VNO tissue taken from a more 
caudal region of the VNO (F) compared to a coronal section taken from a more rostral 
region (G). Both sections are from the same mouse. (H-I) pCREB staining in a coronal 
rostral section showing the intense expression of pCREB (H) in the section of the 
neuroepithelium corresponding to the location of Gαi2-expressing VSNs (I – image from 
(Pantages and Dulac, 2000)). Scale bar, 100 µm. 
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Figure 3.7C. Intriguingly, we saw a non-uniform pattern of expression of pCREB in 
VSNs throughout different rostral/caudal locations in the VNO, with more abundant 
staining in the rostral VNO sections (Figure 3.7G; see schematic for relative position in 
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the VNO, Figure 3.7D, E - from (Salazar I, 1998)), and significantly less staining in 
caudal sections from the same mouse (Figure 3.7F). Additionally, we saw a non-uniform 
distribution of pCREB staining within a single VNO neuroepithelium. The more apical 
region of the neuroepithelium, which primarily contains V1R-type VSNs that express 
Giα2 (Figure 3.7I – image from (Pantages and Dulac, 2000)) more robustly expresses 
pCREB (Figure 3.7H). This particular expression pattern of phosphorylated CREB within 
unstimulated VSNs has never before been reported, and is currently unexplainable based 
upon our current studies, but would be interesting to investigate further. 
 Interestingly, when we exposed mice to pheromones from mice of the opposite 
gender, we observed what appeared to be contrasting expression patterns of pCREB and 
pS6 in our stained VNO tissue sections. To directly confirm our observations, we stained 
VNO sections from unstimulated and stimulated mice with antibodies for pCREB and 
pS6. Indeed, we notice that pCREB and pS6 are not co-expressed in the same VSN 
populations in either unstimulated or stimulated VNO tissue sections. pCREB expression 
is abundant in unstimulated (unexposed) mice, while pS6 levels are low. Upon 
pheromone exposure, pCREB expression is reduced while pS6 expression is induced. 
This pattern of expression for these two markers is intriguing, but as of these studies, we 
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Figure 3.8: Phosphorylated CREB and pS6 exhibit contrasting expression patterns 




(A-B) Coronal section of VNO showing the phosphorylation of CREB (pCREB, red) and 
pS6 (green) in VSNs of unstimulated (non-pheromone exposed) mice (A) and after 
pheromone stimulation (B).  Scale bar, 100 µm. 
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DISCUSSION 
 Animals rely on their sensory systems to receive information around them so that 
they are able to appropriately respond and adapt to their surroundings for survival. Our 
sensory systems are able to detect a variety of stimuli from the environment, e.g. 
chemicals, light, and touch, and each of these sensory systems is optimized for its 
purpose. The initial detection of a stimulus is dependent upon the reaction (usually 
binding) of the stimulus with its corresponding receptor on a peripheral sensory neuron. 
The successive activation of that neuron will then transmit that signal from this primary 
peripheral sensory neuron to its ultimate brain target. 
 When a peripheral neuron becomes activated, many cellular processes within the 
neuron occur, including the induction or repression of particular genes. The discovery of 
genes that are faithfully induced or repressed in an active neuron have thus become 
valuable reporters to assess activity in neurons. Among these, the ones used most 
frequently are cfos and egr1 (Morgan and Curran, 1991). 
 While we were able to visualize robust detection of cfos and egr1 expression in 
the main olfactory system, we could not find a suitable protocol to enable us to see the 
pheromone-stimulated expression of these genes in VSNs. Finding an activity marker for 
VSNs was crucial for our experiments because we needed a method to measure VSN 
responses to pheromones that was reliable and robust. Since we were trying to determine 
whether PDE5A inhibition impeded pheromone delivery to the VSNs, if our readout for 
our non-drug treatments was not robust, we may not see a change in VSN activation after 
inhibitor treatment. Many of these attempts were unsuccessful. Other genes that have 
shown expression upon OSN odor stimulation, Lrrc3b and S100a5 were also analyzed. 
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We did observe staining in VSNs with our S100a5 in situ probe, but this staining was not 
significant enough to use for our analyses under our conditions. 
  With the advent of the phosphorylation of ribosomal protein S6 as a reporter for 
neuronal activity (Knight et al., 2012), we found that pS6 expression was a reliable 
indicator of VSN activation, and the results obtained from these analyses bolstered our 
rhodamine dye findings. While we saw pS6 expression in VSNs, we also saw other cells 
in our VNO sections that exhibited pS6 expression, even without stimulation. We 
observed no marked pattern of pS6 expression in these cell types, but this limited our 
methods of detection. When we attempted to immunoblot for pS6 with whole VNO 
tissue, we did not see any differences between unstimulated or stimulated samples 
(Figure 3.4). Although pS6 is a reliable VSN activity marker, it may not be as sensitive 
for analysis of whole tissue samples. While we did see pS6-positive cells in the accessory 
olfactory bulb of the brain (which is the corresponding area of the olfactory bulb where 
VSNs extend their axons), we observed no significant differences in pS6 in AOB sections 
from unstimulated and pheromone-stimulated mice. 
 Additionally, we utilized this staining to test different concentrations of PDE5A 
inhibitors in this system. 300 µM sildenafil and 100 µM tadalafil treatment repeatedly 
showed a reduction in pS6 staining after stimulation; however, a 3 µM and 1 µM 
concentration of these inhibitors displayed no effect in VSN activation (Figure 3.5). This 
suggested that the optimal concentration of inhibitor to attenuate the VNO pump 
effectively is likely at a concentration between these ranges. Since pS6 immunostaining 
appears to be a fairly sensitive method of VSN activity detection, this concentration may 
be determined. 
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 Furthermore, we also noticed diversity in the number of pS6-positive VSNs in 
female mice stimulated with soiled bedding. Some females displayed a high level of pS6 
in VSNs after pheromone stimulation, while others had noticeably fewer labeled VSNs. 
This observation was seen in all independent stimulation experiments, where all of the 
females used for stimulation on the same day were exposed to the same male 
pheromones. Male mice did not display much deviation in pheromone-induced pS6 
expression in VSNs.  
 At first we were surprised by this result; however, the Stowers lab recently 
showed that when female mice are in the diestrus stage of the estrous cycle, a subset of 
their VSNs are unresponsive to male pheromones, which results from changes in 
progesterone (Dey et al., 2015). Evolutionarily, this silencing of male pheromone-
detecting VSNs in females makes sense – females that are in diestrus are not receptive to 
mating. The use of female mice in many analyses can be challenging due to the 
fluctuation in hormones throughout stages of the estrous cycle. Our methods did not 
differentiate the stage of the estrous cycle of female mice during these stimulations, so 
this phenomenon could be an explanation for the variability in pS6-expression we see in 
female VSNs, although confirming this would require additional tests. 
 Overall, the work in this chapter focused on the development of tools that were 
required to test our main hypothesis, which was essential for our studies. Recently, other 
labs have also mentioned problems with the use of typical immediate early genes, 
specifically in VSNs, so the need for reliable markers of VSN activation may be an 
ongoing process in the field. With many high-throughput methods of sequencing and 
advanced ways of analyzing large-scale data, more activity genes specific to a particular 
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system may be uncovered. While cfos and pS6 are both markers of neuronal activity, the 
expression patterns are not fully overlapping. Some pS6-positive, cfos-negative cells 
have been observed Knight 2012, and vice-versa. This strongly supports the idea of a 
large scale of heterogeneity between different populations of neurons, upon different 
types of stimulations. The use of many markers together and identifying different types of 
cells within a given population may provide insight about the precise population of 
neurons responsible for eliciting a given behavior. There are many diverse types of cells 
in the VNO, so finding and using reliable VSN-specific activity markers may be 
beneficial and necessary for assessing VSN activity with high confidence. 
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METHODS 
Chemicals used for experiments: 
Sildenafil citrate salt (Sigma-Aldrich #PZ0003) 1-3-(4,7-Dihydro-1-methyl-7-oxo-3-
propyl-1H-pyrazolo4,3-dpyrimidin-5-yl)-4-ethoxyphenylsulfonyl-4-methylpiperazine 
citrate salt, 5-2-Ethoxy-5-(4-methylpiperazin-1-yl)sulfonylphenyl-1-methyl-3-propyl-4H-
pyrazolo5,4-epyrimidin-7-one citrate salt 
Tadalafil salt (Sigma-Aldrich #Y0001417) 
2,2 Tribromoethanol (Avertin, Sigma-Aldrich, St. Louis, MO) 
Quantitative  RT-PCR: Adult mice (>2 months of age) were intraperitoneally injected 
with 250 mg/kg body weight Avertin (Sigma) and the VNO was immediately dissected 
and homogenized in TriZol (Life Technologies). RNA was extracted using phenol-
chloroform. Primer sets were designed to recognize cfos and egr1. RT reactions were run 
with 0.5 µg of total RNA for all reactions. Amplification for trpc2 was used as a reaction 
control for the relative amount of VSNs within the total VNO sample tissue.  
 
Primers for cfos (predicted size: 94 bp): 
TCCTACTACCATTCCCCAGC; TGGCACTAGAGACGGACAGA 
Primers for egr1 (predicted size: 131 bp): 
GAGCGAACAACCCTATGAGC; GGCCAGTATAGGTGATGGGA 
Primers for trpc2 (predicted size: 121 bp): 
TCTGTGGCCTCAACAACATC; TCCACCACTGTGTGCTCTTC 
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Tissue Preparation for in situ hybridization/immunohistochemistry: Mice were 
anesthetized using Avertin (250mg/kg body weight), transcardially perfused with 0.1 M 
phosphate buffered saline (PBS), followed by 4% paraformaldehyde (PFA) buffered in 
PBS. Tissue was post-fixed for 1 hour, and then decalcified in 10% 
ethylenediaminetetraacetic acid (EDTA) for 3-4 days. Tissue was cryo-protected in 30% 
sucrose (Sigma-Aldrich, St. Louis MO) dissolved in PBS overnight (approximately 12-16 
hours). Tissue was embedded with OCT (Sakura Finetek), and 14 µm coronal sections of 
the VNO were collected Slides were stored at -80°C until use. 
Immunohistochemistry: Sections were rehydrated in 0.1M PBS for 10 minutes at room 
temperature and permeabilized in 0.1-1% Triton-X-100 for 10 minutes. Slides were 
blocked in 5% goat serum (in 0.1% Triton-X-100/0.1M PBS buffer). Primary antibodies 
were diluted in blocking buffer (see table) and incubated on tissue overnight at 4°C. 
Alexa-Fluor-conjugated secondary antibodies were incubated on tissue for 1-2 hours at 
room temperature. Slides were mounted with Fluoromount (Sigma-Aldrich, St. Louis, 
MO) with DAPI (1:1000) and visualized with confocal (LSM 510/confocor, Zeiss) 
microscopy. 
For colormetric immunohistochemistry, all procedures prior to secondary antibody 
application were identical to those used for fluorescent immunohistochemistry. After 
incubation in primary antibody overnight, slides were washed and treated with a 
Vectastain ABC reagent kit (Vector Laboratories), using a secondary antibody that is 
conjugated to biotin with a streptavidin amplification system. The substrate 
diaminobenzidine tetrahydrochloride (DAB – Sigma-Aldrich #D5637) produces a 
colormetric stain for detection. 
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Antibodies used for Immunohistochemistry: 
Antibody Species Dilution Ordering Info 
pS6 240/244 Rabbit 1:1000 Cell Signaling #2215 
pS6 235/236 Rabbit 1:1000 Cell Signaling #4858 
pCREB Ser 133 Rabbit 1:1000 Cell Signaling #9198 
Egr1 Rabbit 1:500 Santa Cruz #sc-189 
c-fos Rabbit 1:1000 Millipore #pc38 
 
In situ hybridization: All methods described were modified from Ishii et al., 2004. 
Riboprobe templates for cfos, egr1, lrrc3b and S100a5 were created using cDNA from 
isolated brain tissue. Templates were cloned into TOPO-TA vector (Thermo-Fisher, 
Waltham, MA). Plasmids were then linearized using BamHI and XbaI restriction 
enzymes (New England Biolabs, Ipswich, MA). Linearized plasmids were phenol-
chloroform purified for in vitro transcription reactions. BamHI-cut inserts were 
transcribed with T7 RNA polymerase (Invitrogen, Grand Island, NY) and XbaI-cut 
inserts were transcribed with Sp6 RNA polymerase (Ambion, Grand Island, NY).  
All solutions used prior to probe hybridization were treated with 
diethylpyrocarbonate (DEPC) (Sigma-Aldrich, St. Louis, MO). VNO cryosections were 
post-fixed in 4% paraformaldehyde for 15 minutes at room temperature and washed in 
0.1M PBS/DEPC. Tissue was digested with Proteinase K (10 µg/mL in Tris buffer) for 
10 minutes at 37°C and post-fixed in 4% PFA for 10 minutes at room temperature. Slides 
were washed in 0.1M PBS/DEPC and incubated in 0.2N HCl for 20 minutes. Slides were 
acetylated in acetic anhydride/triethanolamine (acetylation buffer) and dehydrated 
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subsequently in 60%, 80%, 95%, 100% and 100% ethanol. Samples were air-dried for 10 
minutes and equilibrated in Hybridization Buffer for 1 hour at room temperature in a 
humid chamber. Probes were diluted in Hybridization Buffer (0.1-0.3 µg/100 µL) and 
heated at 85°C for 3 minutes to prevent secondary structure formation. 100 µL of 
probe/hybridization buffer was applied to coverslips and slides were inverted and placed 
face down onto coverslips. Probes were hybridized for 12-16 hours in a humid chamber 
set to 65°C. Following overnight hybridization, coverslips were removed from slides and 
washed in 2XSSC/50% formamide for 30 minutes at 55°C and then in 0.2X SSC (x3) at 
55°C. Slides were equilibrated in 10% donkey serum block (TNB buffer) for 1 hour at 
room temperature in a humidified chamber. Anti-DIG-AP Fab Fragment antibody 
(Invitrogen, Grand Island, NY) was diluted 1:5000 in TNB buffer and 200 µL of 
antibody/TNB buffer was applied to each slide, covered with strips of parafilm and 
incubated at 4°C overnight. After 12-16 hours, slides were washed in TN buffer and then 
equilibrated in a magnesium-based buffer for 10 minutes at room temperature. 1 
NBT/BCIP tablet (Roche) was dissolved in 10 mL distilled water and precipitate was 
removed using a sterile filter. Solution was generously applied to slides and slides were 
kept in the dark for 2-6 hours and monitored intermittently for alkaline phosphate 
colormetric precipitate, using sense-treated slides as a control. Slides were then washed in 
0.1M PBS and sterile water and cover-slipped with Fluoromount aqueous mounting 
medium (Sigma-Aldrich, St. Louis, MO). 
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Primers to make cfos anti-sense probe sequence (predicted size: 905 bp): 
AGAATCCGAAGGGAACGC; GGAGGCCAGATGTGGATG 
Primers to make S100A5 anti-sense probe sequence (predicted size: 264 bp): 
GCTGACCCTGAGTAGGAAAGAA; ATAGGAGGGGCAGTTAAAGAGG 
Primers to make Lrrc3b anti-sense probe sequence (predicted size: 898 bp): 
TGAACCACCCAGGAAGGA; CCAGCCAGCATGGCTACT 
 
Western Blot: Adult mice (>2 months of age) were single-housed for 1 day. For 
pheromone stimulation, mice were placed into a soiled cage (from mice of the opposite 
gender) for 30-45 minutes. After stimulation, mice were intraperitoneally injected with 
250 mg/kg body weight Avertin and the vomeronasal organ was immediately removed 
and homogenized in 2X laemmli buffer and stored at -80°C. Concentration of total 
protein was determined using a standard BCA Assay. 10-20 µg of total VNO protein was 
run on an SDS-PAGE gel, followed by transfer onto a PVDF membrane. Membrane was 
blocked in 5% bovine serum albumin (BSA) in 20 mM Tris, 150 mM NaCl, and 0.1% 
Tween-20 for 2 hours at room temperature. Primary antibodies (see table below) were 
diluted in blocking reagent and incubated overnight at 4°C with gentle agitation. 
Membranes were washed in TBST (20 mM Tris, 150 mM NaCl, 0.1% Tween-20) buffer 
and secondary antibodies conjugated to HRP (horse radish peroxidase) were applied and 
incubated for 2 hours at room temperature. An ECL Plus reagent kit (GE Life Sciences) 
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Antibodies used for Western Blotting: 
 
Antibody Species Dilution Ordering Info 
pS6 240/244 Rabbit 1:1000 Cell Signaling #2215 
S6 Rabbit 1:1000 Cell Signaling #2217 
OMP Goat 1:10,000 
Margolis Lab 
University of Maryland 
	  
 
Statistical analyses: Statistical analyses were all performed with GraphPad Prism 
software. All Student’s t tests were performed assuming Gaussian distribution, two-tailed, 
unpaired, and a 95% confidence interval. One-way or two-way ANOVA was used for 



























CHAPTER 4: INHIBITION OF PDE5A IN THE VOMERONASAL ORGAN  
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ABSTRACT 
 Many non-primate mammalian species rely on the detection of odors and 
pheromones to gain insight regarding food sources, dangerous toxins, individual identity, 
and potential mates. Pheromones are specialized odors that elicit innate conspecific 
behaviors in many animals. It is now known that the main olfactory system is able to 
detect and respond to pheromone cues, with surgical removal or ablation of sensory 
neurons in the vomeronasal system resulting in altered responses and behaviors reliant 
upon pheromone detection (Wysocki, 1979, Wysocki and Lepri, 1991, Wysocki et al., 
1982, Beauchamp et al., 1982, Beauchamp et al., 1985, Lepri and Wysocki, 1987). The 
detection of pheromones by VSNs can be monitored through the use of neuronal activity 
markers (see Chapter 3), electrophysiological recordings of VSNs (Holy et al., 2000, 
Leinders-Zufall and Zufall, 2013, Ukhanov et al., 2007), or recordings from neurons 
within the accessory olfactory bulb of the brain (Ben-Shaul et al., 2010); however, a 
disruption in many of these analyses does not necessarily equate to perturbation of an 
animal’s perception of pheromones, or changes in behavioral responses to pheromones. 
In Chapter 2, we have described the expression of PDE5A in the blood vessel region of 
the VNO and propose a necessity of PDE5A for pump function and delivery of 
pheromones to the lumen of the VNO. Furthermore, in Chapter 3, we have observed a 
reduction in VSN activity upon exposure to pheromones after PDE5A inhibitor treatment, 
which may be attributed to the prevention of pheromone access into the VNO to trigger 
VSN activation. In this chapter, we examine whether this reduced VNO pump activity 
results in functional consequences as assayed with overall behavioral responses to 
pheromones. We find that the drug-induced attenuation of the pump activity significantly 
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alters an animal’s innate behavioral responses to pheromones. Additionally, we describe 
methods to more directly measure pump activity in vivo while simultaneously observing 
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INTRODUCTION 
 Chemosensation is a modality that animals have evolved to detect a wide range of 
chemicals from their environment, enabling them to gain incredible amounts of insight 
about their surroundings to appropriately respond to a given stimulus. The vomeronasal 
system is a specialized chemosensory system that has been shown to detect pheromones, 
a subclass of odors that individuals secrete into the environment, which can then elicit 
innate behaviors in other animals including aggression, fear, and mating. Despite recent 
studies demonstrating that both the main olfactory system and the vomeronasal system 
(along with other chemosensory structures in the nasal cavity) are able to detect 
pheromones (Liberles and Buck, 2006, Spehr et al., 2006a), surgical removal or ablation 
of the vomeronasal organ results in a distinct loss of behaviors believed to be driven by 
pheromone detection (Wysocki, 1979, Wysocki and Lepri, 1991, Wysocki et al., 1982, 
Beauchamp et al., 1982, Beauchamp et al., 1985, Lepri and Wysocki, 1987). While the 
existence and importance of this system in humans and primates is debated (Besli et al., 
2004, Meredith, 2001), its function in other animals can be crucial to their survival and 
reproductive potential.  
 Although the main olfactory and vomeronasal systems are similar in some ways, 
such as their striking ability to regenerate sensory neurons (Conzelmann et al., 2001, 
Graziadei and Graziadei, 1979a, Graziadei and Graziadei, 1979b, Graziadei et al., 1980, 
Graziadei et al., 1979, Graziadei and Monti Graziadei, 1980, Wilson and Raisman, 1980), 
and the pseudo-stratified organization of their sensory epithelia, there are significant 
differences between these systems. For example, volatile odorants simply diffuse into the 
nasal cavity to bind odorant receptors on OSNs, whereas the structural features of the 
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VNO prevent pheromones from passively diffusing into the lumen, and therefore, they 
must be actively pumped into the organ for detection.  
 Another substantial difference between the systems is the general behavioral 
responses elicited upon the activation of each system’s sensory neurons. Perturbations in 
essential components in the main olfactory sensory neurons impact an animal’s ability to 
locate food and avoid toxins (Wysocki et al., 1982). Disruptions to vomeronasal sensory 
neurons primarily result in alterations to an animal’s detection, perception and responses 
to another animal (Bean and Wysocki, 1989, Beauchamp et al., 1982, Wysocki, 1979, 
Wysocki and Lepri, 1991). Examples of behaviors used to analyze vomeronasal 
dysfunction include those associated with mating or innate territorial aggression 
(Chamero et al., 2007, Papes et al., 2010, Connor and Lynds, 1977, Maruniak et al., 1986, 
Wekesa and Lepri, 1994).  
 This chapter focuses on utilizing common behavioral assays that are often 
indicative of vomeronasal function to further analyze the potential role of PDE5A in 
VNO pump delivery of pheromones to the sensory neurons for detection. This will allow 
us to determine if our method of pharmacologically inhibiting PDE5A in the VNO, which 
inhibits pheromone-stimulated activation of VSNs (see Chapter 3), also results in 
physiological consequences for the animal. Alterations in an animal’s ability to properly 
detect and respond to pheromones were examined using a standard behavioral paradigm.  
 In our studies, we found that treatment with PDE5A inhibitors was sufficient to 
elicit aberrations in innate male-male aggressive behaviors, while seemingly not affecting 
mating behaviors in these sexually-experienced male mice. Moreover, we also describe 
modified methods previously used in hamsters to measure VNO pump function in real 
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time both in vivo and ex vivo. The development and refinement of this technique may be 
useful in further understanding the direct consequences of pharmacologically inhibiting 
the VNO pump in real time. 
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RESULTS 
Pheromone-dependent male-male aggressive behaviors are disrupted after local 
application of PDE5A inhibitors to the VNO 
 The reduced pheromone delivery and subsequent decreased activation of 
vomeronasal sensory neurons after PDE5A inhibitor treatment could lead to alterations in 
behaviors dependent on pheromone sensing by the vomeronasal system. To test the 
behavioral consequence of inhibiting PDE5A in the VNO, we utilized a well-established 
behavioral test, the aggressor-intruder paradigm, in male mice (Koolhaas et al., 2013), 
wherein, male mice display innate aggressive behaviors toward any foreign males 
introduced into their home cage (Prince et al., 2013, Norlin et al., 2003, Stowers et al., 
2013, Stowers et al., 2002, Koolhaas et al., 2013).  
 For this behavioral assay, ten single-housed, sexually-experienced adult mice 
were used as aggressors. Each aggressor received one treatment of either sildenafil, or 
tadalafil, or saline administered locally to the nose, followed by one trial per day. The 
treatments were randomized for each of the 10 days of testing. All aggressors eventually 
received all potential treatments at least twice during the entirety of the test (Table 4.1). 
After local application of PDE5A inhibitor or saline, the aggressor was returned to its 
home cage for 30 minutes prior to performing a trial. For each trial, an intruder male 
mouse was placed into the aggressor’s cage and video-recorded for 10 minutes. These 
recordings were blindly analyzed at a later date.  
 Saline-treated aggressors attack unfamiliar male intruders for 10-15% of the 10-
minute trial time (Figure 4.1A, B, black dots, also see Supplemental Video “Zhao S1  
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On Day 1, two trials were performed on mice 3834, 3835, 3840, and 3915. All second 
trials were mating trials. 30 minutes before each trial, mice were administered treatment 
according to the schedule. Trials were at least 3 hours apart. 
 
** Denotes that mouse 3840 was not treated/tested on Days 7-10. 
  
	  
	   99 
Figure 4.1: Locally inhibiting PDE5A in the VNO alters innate pheromone-based 







(A-C) Local administration of phosphodiestase 5A inhibitors, sildenafil citrate (red) and 
tadalafil citrate (blue), to the nasal cavity of aggressor male mice reduces aggressive 
attack behaviors toward intruder male mice (A, B) and attenuates time until the first 
attack toward intruders (C) compared to saline-treated aggressors (black) (See 
Supplemental Videos). Error bars indicate SEM, N = 9 mice, with at least 17 trials (n=) 
per condition. Dots indicate individual trials performed. **p<0.01, **** p < 0.0001 as 
assessed with ANOVA.  
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Saline Intruder”). The first attack was initiated within the first minute after the intruder 
was placed in the aggressor’s cage (Figure 4.1C, black dots). When PDE5A inhibitors 
were applied to the VNO of aggressors, they attacked the intruders less frequently (Figure 
4.1A, red and blue dots, see Supplemental Video “Zhao S2 Sildenafil Intruder” and 
“Zhao S3 Tadalafil Intruder”) and the duration of attacks was also reduced (Figure 4.1B, 
red and blue dots), with the first attack also significantly delayed (Figure 4.1C, red and 
blue dots). These data suggest that inhibiting PDE5A in the VNO results in altered 
pheromone-dependent aggressive behavior in male mice. 
 
Local inhibition of PDE5A in the VNO of male mice does not affect behaviors 
associated with mating  
 In conjunction with the male-male aggressive behavioral test, we intermittently 
introduced a female intruder in place of the male intruder and analyzed the aggressor’s 
behavior during a 5-minute trial. All aggressors, regardless of being treated with PDE5A 
inhibitor or saline, actively investigated the female intruders, and many initiated mating 
with them (Figure 4.2A, B, also see Supplemental Videos “Zhao S4 Saline Female,” 
“Zhao S5 Sildenafil Female,” and “Zhao S6 Tadalafil Female”). This observation 
suggested that inhibiting PDE5A in the VNO did not affect behaviors associated with 
male-female mating in sexually-experienced male mice. 
 
Individual male mouse behavior over the course of the behavioral assay  
 In addition to the quantification we performed by pooling the mice into 3 defined 
groups (saline, sildenafil, or tadalafil-treated), we were also able to track and analyze an  
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Figure 4.2: Local inhibition of PDE5A in the VNO of male mice does not affect 







(A-B) Mating behaviors of aggressors with female mice were unaffected by local 
pharmacological inhibition of PDE5A when assaying the total # of mounts (A) and the 
total time spent mounting females (B) (See Supplemental Videos). Error bars indicate 
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(A-C) Individual aggressor behavior quantified over the entire course of the behavior 
experiment showing the total number of attacks in one trial (A), the total attack time (B), 
and the latency to the first attack (C). Averages are calculated from all analyzed videos 
for each aggressor. 
 
*Note: Aggressor 3920 was removed from all final data sets in publication because of the 
lack of aggressive behavior toward intruders throughout the course of the 
experiment.behavior data (total # of attacks, attack time and latency to first attack) for 
each mouse, color-coded for each type of treatment (Figure 4.3; saline, black; sildenafil, 
red; tadalafil, blue). 
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individual mouse’s attack behavior after each treatment during the entirety of the 
experiment (Figure 4.3). Each mouse has a different innate intrinsic level of activity and 
aggressive behavior. Thus, to ensure that the mice we chose for our analyses were 
exhibiting typical levels of activity and natural aggression, we plotted the average 
behavior data (total # of attacks, attack time and latency to first attack) for each mouse, 
color-coded for each type of treatment (Figure 4.3; saline, black; sildenafil, red; tadalafil, 
blue). 
 Analyzing the behavior for individual mice was very useful, showing one mouse 
(#3920) exhibited abnormally low levels of aggression under all conditions, allowing us 
to exclude this mouse from our final analysis. Additionally, over the course of the 
behavioral experiment, one mouse (#3840) developed severe aggressive behavior, 
attacking a female intruder mouse during a mating trial on Day 7. Trials on previous days 
did not show any abnormally aggressive behavior, so we included the data from this 
mouse until Day 7 and excluded data from Days 8-10.  
 
Local application of PDE5A inhibitors to the VNO alter VNO pump recordings and 
affect investigational activities of a mouse during an in vivo VNO recording 
 To measure movement of the VNO pump in real time, we attempted to optimize a 
more quantitative in vivo approach, adapted from its original use in hamsters (Meredith, 
1994). This method involves implanting conductive wires at a fixed distance from each 
other in the VNO (Figure 4.4A), and measuring the change in voltage between the two 
wires as a constant current is generated through the system (see inset zoomed image, 
Figure 4.4A’). The wires are then drawn along the cheek and skull, and finally cemented 
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to the mouse’s skull with golden pins (Figure 4.4B, D). One pin was connected to a 
current generator (Grass Instruments) (Figure 4.4C, current generator, and 4.4D), and the 
other pin was connected to a phase-lock amplifier (EG&G Princeton Applied Research), 
which amplified the signal from the wires and filtered out environmental noise in the 
system (Figure 4.4C, phase-lock amplifier #5210, see methods for additional details). In 
this setup, the mouse served as a conduit through which electrical current passes, thus 
completing the circuit (Figure 4.4D). Voltage was reported as a read-out of the circuit 
(current is held constant at a frequency of 500 Hz), and a change in the voltage was 
interpreted as a change in resistance in the VNO tissue (Figure 4.4F). Presumably, the 
movement was correlated with the pumping function of the VNO. 
 A mouse was connected to the circuit (Figure 4.4B) and placed in an arena with 
clean bedding and allowed to freely roam throughout the course of the in vivo recording 
(Figure 4.4E). Since VNO activity can also be induced by a novel environment, we 
connected the output to an oscilloscope and visualized the spikes induced from the novel 
environment in real time, and did not begin our experiments until very few spikes were 
seen (“experimental baseline”), and the mouse settled into the arena (approximately 5 
minutes). We then placed a petri dish filled with soiled bedding from another male mouse 
into one side of the cage. We video-recorded the 5-minute trial and analyzed the amount 
of time the mouse spent with the pheromone dish, which was correlated with the number 
of spikes recorded (as a stronger indicator of the spikes being from the pheromone-
induced voltage change we were seeing from the traces). 
For the first experimental trial, we administered saline to the tip of the mouse’s 
nose, returned the mouse to its home cage for 30 minutes and then moved the mouse to 
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Figure 4.4: Setup of the VNO wire recording experiment. 
 
 
(A) Ventral view of the VNO in a mouse, showing the surgical procedure for the 
placement of conductive wires within the nasal cavity (A), with a zoomed in view to 
show the wire placement in the VNO (A’). (B) Photo of a mouse 5 days after wire 
placement surgery, showing the location of the golden pins onto the top of the head. (C) 
Photo of the equipment required for the recording procedure. Constant current is 
generated (current generator), which then passes through a stimulus isolation unit (SIU). 
From here, the current flows to one golden pin on the mouse, through the mouse, out of 
the other golden pin, and to the dual phase-lock amplifier, where environmental noise is 
filtered out and the actual readout is amplified. (D) General schematic (from ) of the 
connectivity of the system. (E) Photo showing the setup for a recording session. The 
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Figure 4.5: Local application of PDE5A inhibitors affects VNO pump recording –  
in vivo VNO wire recording experiment. 
(A) VNO recording trace from a live mouse in the arena with pheromones after no drug 
application. (B-F) VNO recording trace from a live mouse in the arena with pheromones 
35 minutes (B), 60 minutes (C), 95 minutes (D), 125 minutes (E), and 155 minutes (F) 
after tadalafil application to the tip of the nose. (G) Quantification of the total time the 
mouse spent with the pheromones placed in the arena, normalized to the time spent with 
the pheromones with no drug applied. (H) Total number of VNO recording spikes per 
time spent with the pheromones in the arena, normalized to the number of spikes per time 
spent with the pheromones with no drug applied. (I) Area under the curve (AUC) of the 
spikes per time spent with the pheromones in the arena, normalized to the AUC of spikes 
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begin the trial in the recording arena. We waited until the mouse acclimated to the arena, 
and then began the experimental recording.  
 After the saline treatment, the mouse actively investigated the petri dish filled 
with soiled mouse bedding, but also spent a large portion of its time freely moving 
around the entire arena. The mouse spent only about 15-20% of its time investigating the 
soiled bedding (Figure 4.5G) and the recorded traces showed very active spike patterns 
during this time (Figure 4.5A). After this recorded 5-minute trial, the mouse was removed 
from the arena, treated with sildenafil or tadalafil via local application to the tip of the 
nose, and placed back into its home cage for 30 minutes.  
 With the PDE5A inhibitor treatment, fewer spikes were seen throughout the 
experimental recording (Figure 4.5B). Additionally, the mouse spent more time with the 
soiled bedding than the initial trial (Figure 4.5G), despite the marked reduction in 
recording spikes observed. When the number of spikes and area under the curve (AUC) 
of the spikes was normalized to the amount of time the mouse spent with the bedding, 
there was even more of a significant difference between the saline treatment trial and the 
trials performed after inhibitor treatment. Although the mouse spent more and more time 
investigating the soiled bedding (as opposed to also freely roaming the arena), fewer and 
fewer spikes were seen during the recording (Figure 4.5H-I).  
 After the recording, the mouse was returned to its home cage and allowed to rest 
for 25-30 minutes until the next soiled bedding recording to determine the duration of 
drug inhibition. Subsequent recordings showed fewer and fewer spikes (Figure 4.5C-F), 
and the mouse spent longer periods of time with the bedding in each trial (Figure 4.5G). 
When the number of spikes and the AUC of the recorded spikes were normalized to the 
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amount of time the mouse spent with the soiled bedding, there is a dramatic decrease in 
this ratio after tadalafil treatment (Figure 4.5H-I). 
 This pattern of behavior was a bit surprising at first, but since the mouse exhibited 
fewer recorded spikes after PDE5A inhibitor treatment, the data potentially suggests that 
inhibiting PDE5A attenuates the VNO pumping activity, resulting in fewer recorded 
spikes. If the pump is not functioning properly, the mouse may not efficiently detect the 
pheromones from the bedding as well as it normally would be able to, and thus spends 
more time with the pheromones to try to compensate for this attenuated detection. 
 
Ex vivo SCG stimulation of the VNO may be useful to monitor VNO activity  
 Additionally, we tried to control this VNO recording paradigm further and 
artificially control the VNO pump by stimulating the superior cervical ganglion (SCG) 
with a current generator. The SCG is the origin of the sympathetic fibers that innervate 
the VNO to initiate the constriction of the VNO pump in response to novelty or 
pheromones (Meredith and O'Connell, 1979). Stimulating the SCG required superficial 
surgical methods to expose the ganglion and the SCG fibers, without damaging any of the 
tissue. To do this, we cut open the skin near the left shoulder/neck and dissected the 
tissue obstructing the SCG (Figure 4.6G).  
 To test our current setup and apply ex vivo SCG stimulation to the system, we first 
stimulated the SCG and observed the effects of pupil constriction/dilation (Figure 4.6F), 
which is a more direct, quicker readout of SCG stimulation than our recordings. 
Therefore, we lightly anesthetized a mouse, and stimulated the SCG with a tungsten 
electrode that we created (see methods). We applied 0.1 - 1 V of stimulation, and using  
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Figure 4.6: Ex vivo VNO recording setup with SCG stimulation. 
(A) General setup for the ex vivo pupil recording, showing the mouse mounted onto a 
platform with electrodes inserted onto the superior cervical ganglion (SCG) and the 
infrared camera recording pupil constriction. (B) Photo from an infrared camera of the 
pupil with no SCG stimulation. (C) Photo of the same pupil after 0.5 V of stimulation to 
the SCG. (D) Photo of the same pupil immediately after current stimulation to the SCG is 
turned off. (E) Photo of the same pupil immediately after 0.5 V stimulation is again 
applied to the SCG. (F) General setup for the ex vivo VNO recording, showing the mouse 
mounted onto a platform with electrodes inserted onto the SCG and the electrodes 
attached to golden pins on the mouse’s head to record the current flow through the VNO. 
(G) Photo of the exposed SCG required for the procedure. The SCG, carotid artery, and 
sympathetic fibers are carefully exposed for the stimulation. (H) Photo of the VNO wires 
freshly placed into the VNO to record the current flow through the VNO. (I) Recording 
trace of the applied current stimulation to the SCG. (J) Example trace of the current flow 
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an infrared camera in low light conditions, we video-recorded the pupil response before, 
during, and after the stimulation (Figure 4.6A).  
 In low light conditions prior to any SCG stimulation, the pupil is slightly dilated 
(Figure 4.6B). When 0.1 - 1 V of stimulation is applied to the SCG, there is a rapid 
dilation response (Figure 4.6C). When the stimulation is removed (the generator is turned 
off), the pupil returns to a size similar to before the stimulation (Figure 4.6D). When the  
same paradigm of stimulation was applied again to the SCG, the pupil dilated to the same 
size as during the previous stimulation (Figure 4.6E). This suggested that the dilation we 
were seeing was resulting from the externally applied stimulation. 
 We next tested mice that had wires previously implanted into the VNO (same 
surgical methods as for the in vivo VNO recording) to measure VNO activity upon SCG 
stimulation. We lightly anesthetized post-surgical mice, exposed and stimulated the SCG 
as was performed for pupil stimulation, and recorded the VNO response before, during, 
and after SCG stimulation with the same equipment as in the in vivo recording (Figure 
4.6F). We also freshly implanted wires into the VNO on the same day, prior to the 
recording, and tested the response in the same manner (Figure 4.6H). Prior to SCG 
stimulation, the recordings show baseline spiking activity, indicating that without 
artificial SCG stimulation, the VNO tissue appears to be pumping to some degree (Figure 
4.6J). When stimulation is applied to the SCG (Figure 4.6I, dark blue pulses), the 
recorded VNO response shows a different pattern of spikes, with the spikes becoming 
shorter, rhythmic, and more frequent (Figure 4.6J). The unstimulated VNO recording 
trace is displayed beneath the corresponding stimulation trace (Figure 4.6I). These results 
suggested that the stimulation we were providing to the SCG was potentially affecting the 
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recorded signal in some way, although the interpretations of results from these 
experiments cannot be fully conclusive.  
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SUPPLEMENTAL FIGURES AND VIDEOS 
 
Supplemental Videos: Videos from Resident Aggressor Behavior 
 
All videos are stored on a separate external hard drive in the Zhao laboratory. 
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DISCUSSION 
 The ultimate result of sensory detection is the transmittance of a signal to 
appropriate regions of the brain that allow an animal to process and perceive information 
about the stimulus and decide (consciously or subconsciously) how to react. Some 
behaviors can be reinforced and learned, and some behaviors are innate and require no 
previous experience for a reaction.  
 Animal behaviors are fascinating – they are incredibly individualistic and can 
vary greatly depending upon the particular animal, its surroundings, and its previous 
experiences. Analyzing animal behaviors in a research setting can therefore be 
challenging for many of these reasons, but can be critical for understanding how a neural 
system functions and whether any perturbations to this system have an overall 
physiological impact on an animal.  
 Many behavioral assays in rodents involve conditioning or training the animal to 
respond to a stimulus and then analyzing any alterations of those behaviors after a 
disruption to the system. These types of assays are often difficult to interpret for many of 
the reasons listed above. Innate behavioral responses do not require any previous 
experience to elicit a reaction, and can consequently be less subjective. 
 Many odors induce instinctive responses such as finding food and avoiding 
predators. Pheromones are a subclass of odors that elicit many innate behaviors in 
animals associated with mating and aggression. It has been shown that the detection of 
many of the pheromones responsible for inducing aggressive behaviors in male mice are 
detected and processed by the vomeronasal system (Chamero et al., 2011, Maruniak et 
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al., 1986, Montani et al., 2013), and therefore can be utilized to assess the functionality of 
the vomeronasal system. 
 Using this behavioral assay, we found that PDE5A inhibitor treatment to our 
aggressor male mice drastically decreased their overall aggressive behavioral responses 
toward an intruder male mouse (Figure 4.1). This suggests that PDE5A inhibitors are 
potentially affecting VNO pump activity to a degree that is observable in a behavioral 
context. In the early 2000s, two independent labs showed that genetically ablating an 
essential signal transduction component in VSNs, transient receptor potential cation 
channel subfamily c member 2 (Trpc2), dampened male-male aggressive behaviors 
toward other male mice (Leypold et al., 2002, Stowers et al., 2002). Many male 
aggressors also initiated mating with the male intruder mice. Although we did not see 
such drastic alterations in behaviors as they saw in their knockout mice, pharmacological 
inhibitors are not 100% efficient, and some pump activity may still be retained in the 
aggressors.  
 The results seen with the use of drugs to inhibit enzymes in an in vivo system can 
sometimes be difficult to interpret. Drugs have off-target effects, and it is not possible to 
analyze every potential system that may be affected by drug treatment. PDE5A has also 
been implicated to have many long-term impacts on cognition and memory (Boccia et al., 
2011, Jin et al., 2014, Reneerkens et al., 2012, Uthayathas et al., 2013, Zhang et al., 
2013), and off-target inhibition of other phosphodiesterases, such as PDE6 in the eye 
Foresta et al., 2008. Additionally, sildenafil has been shown to increase aggressive 
behaviors in male mice after prolonged sildenafil treatment (Hotchkiss et al., 2005, 
Milman and Arnold, 2002). So, to attempt overcome these possible complicating factors, 
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we only treated aggressors with doses of sildenafil or tadalafil once a day for only 10 
days. The fact that we see less aggressive behaviors in PDE5A inhibitor-treatment male 
aggressors suggests that our treatment was not inducing this long-term effect. 
 The male resident aggressors used for this behavioral assay were all sexually-
experienced adult male mice. We observed no obvious alterations in mating behaviors 
when aggressor mice treated with PDE5A inhibitors were introduced to a female intruder 
(Figure 4.2). This could be the result of compensation from the main olfactory system 
(since we did not observe PDE5A expression in the main olfactory epithelium, and 
subsets of olfactory sensory neurons are able to detect pheromones), or previous mating 
experience overcoming the lack of pheromone detection by the vomeronasal system. It 
has been shown that surgically ablating the VNO does not affect mating behaviors in 
sexually-experienced rodents (Beny and Kimchi, 2014, Pfeiffer and Johnston, 1994, 
Ballard and Wood, 2007), and we propose that a similar mechanism may be 
compensating in these PDE5A inhibitor-treated male mice to allow them to retain mating 
capabilities. Alternatively, visual and auditory cues may also be sufficient to induce 
mating behaviors. Therefore, the exact compensatory mechanisms in our paradigm are 
currently unknown, but may be interesting avenues to explore, especially those involving 
sexually-inexperienced male mice.  
 In this chapter, we have also described a recording method modified from its 
original use in hamsters to visualize VNO pump activity (Meredith, 1994). Many 
technical aspects regarding the surgical procedures, equipment setup, and recording 
methods were adjusted and tested to optimize this recording in mice for our purposes. 
When we recorded VNO pump movements in awake, active mice that had the wires 
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implanted into their VNO (Figure 4.4A), we saw some spiking signal in our readout 
(Figure 4.4F, example trace). Although we observed this signal in a few mice, only 
approximately 20% of the mice in we implanted wires showed any spiking activity under 
any conditions. Thus, all of the experiments we conducted included mice that consistently 
showed spiking activity. While we weren’t sure of the exact mechanism responsible for 
the spikes that we saw, we decided to test the spiking activity in these mice when they 
were treated with PDE5A inhibitors. The benefit of this system is that inhibitor treatment 
is transient, so mice can be used more than once for recordings. Furthermore, basal 
spiking activity for each mouse can be established and compared to activity after PDE5A 
inhibitor treatment. Thus, each mouse serves as its own internal control for all recordings. 
If changes in spiking activity in a mouse were observed after inhibitor treatment, this 
recording activity paired with our previous data may suggest that the signal we are seeing 
from this recording is from the VNO. 
 Since the mice were awake during the recordings, we could simultaneously 
analyze behaviors and correlate them with the recording activity we saw. General activity 
and exploratory behaviors could also be analyzed to ensure that inhibitor treatment was 
not globally impacting these parameters. To measure the animal’s behavior in response to 
pheromones, we placed a petri dish with soiled bedding from another mouse into one 
section of the arena and video-recorded the trials. We could also correlate the spiking 
activity we saw with the time the mouse spent with the soiled bedding to further support 
the notion that recording spikes we saw were from VNO activity. 
 When we performed these experiments, we noticed that after inhibitor treatment, 
the mouse spent more time with the soiled bedding (Figure 4.5G), but fewer spikes were 
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observed from our recordings (Figure 4.5). This could suggest that the inhibitor treatment 
may have attenuated the VNO pump, so the mouse was unable to effectively detect the 
pheromones from the soiled bedding, and as a result, spent more time trying to sample 
the pheromones. 
 Preliminary trials with measurement of spike activity during ex vivo SCG 
stimulation were also performed, and the corresponding recording response was analyzed 
(Figure 4.6). Although this technique may provide a more controlled paradigm to 
measure and correlate spike activity, the exact parameters for stimulation need to be 
further optimized. 
 Overall, this chapter describes some in vivo innate behaviors in mice, and 
addresses whether PDE5A inhibition in the VNO is sufficient to disrupt behavioral 
responses that are dependent on the efficient detection of pheromones. While these 
behavioral studies can provide insight about the physiological consequences of perturbing 
the VNO pump, these behavioral responses are highly complex and involve multiple 
brain regions and circuits functioning together properly to elicit the responses. These 
analyses do corroborate our findings from our other assays, but some level of caution is 
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METHODS 
Resident-Intruder Aggression Assay: Resident (aggressor) male mice at least 5 months 
of age were single-housed for at least four weeks prior to testing. Bedding from the 
resident male was left in the cage prior to experimentation (for approximately 5-9 days), 
since territoriality is strongly based upon the presence of olfactory cues. These cues are 
both important for the resident in establishing its own territory and for the intruder to 
know that it is in the home cage of the resident (aggressor). One hour prior to testing, 
female mice were removed from resident cage. 30 minutes prior to recording, aggressors 
were administered 10 µL of sildenafil citrate (30 mM), tadalafil citrate (5 mM) or saline 
vehicle via application to the tip of the nostril. Intruder mice were unfamiliar male mice 
that had never been previously housed with the resident male and were usually smaller in 
size than the resident and group-housed with other male littermates. Intruders were 
placed inside the aggressor's large plastic cage (48 cm × 27 cm × 20 cm) for 10 minutes. 
These 10-minute sessions are repeated daily (with various intruders) for 5 consecutive 
days and video-recorded for analysis. Videos were analyzed for latency to first attack, 
total attack number, and total attack duration. After each session, intruders are analyzed 
for bites and are treated for any injuries. Each intruder will only be used in one 10-minute 
session per day and will be given extra time to recover from any injury, if necessary. To 
assay mating behaviors, female mice at least 3 months of age are placed in an aggressor’s 
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VNO Pump Recordings 
Wire preparation: Two small pieces of insulated wire, approximately 50 µm in diameter 
were cut to approximately 68.5 mm in length (A-M Systems, Carlsborg WA). Insulation 
from both ends of each wire was removed using a butane torch. Using pliers, golden male 
connector pins (A-M Systems, Carlsborg WA) were clamped to one end of each burnt 
wire and reinforced with silver epoxy glue (MG Chemicals, Surrey British Columbia). 
Both wires were twisted tightly together, but the very ends of one side were left untwisted 
(these ends are eventually secured into the drilled holes in the VNO during the surgery). 
A voltameter was used to ensure conductivity of the wires connected with the golden 
pins. 
VNO Surgery: Adult male mouse (>3 months of age) were intraperitoneally injected 
with 250 mg/kg body weight Avertin (2,2 Tribromoethanol) (Sigma-Aldrich, St Louis, 
MO). After a few minutes, mice received a subcutaneous injection of 0.2 mL of Avertin 
to sustain prolonged anesthesia throughout surgery. All areas were thoroughly cleansed 
with 70% ethanol and betadine prior to any incisions. Once a mouse was no longer 
responsive, an 18-gauge trochar (BD Syringe) was guided through the left cheek (near the 
whiskers) carefully underneath the skin until the needle end emerged through the skin at 
the top of the head (positioned approximately 3 mm above the eyes). Twisted wires were 
fed through the pointed side of the trochar so that the VNO-side ends protruded from the 
cheek. The mouse was then turned over and situated onto a platform, and the jaw was 
loosely mounted open. An Olympus SZ40 3X-dissecting microscope (Center Valley, PA) 
was used to magnify the oral cavity for all fine surgical procedures. 6-0 sutures (Harvard 
Apparatus, Holliston, MA) were used to secure the jaw in an open position. The palate 
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was superficially cut to expose the vomeronasal organ. Excess blood was removed with 
cotton swabs or an aspirator. The palate was held open with 6-0 sutures pinned to the 
platform. Cotton swabs were used to dry the area well. 200 µm-size holes approximately 
3 mm apart were drilled in the rostral area of the VNO using a dental drill. Cotton swabs 
or an aspirator were used to remove excess blood. The 18-gauge trochar was fed through 
the inside of the cheek (in an area near the drilled holes) to an area near where the wire 
already protrudes through the cheek. Twisted wires were fed through the trochar using 
forceps. Care was taken to prevent damaging the insulated wires. Hooks were created on 
the ends of the wires located in the VNO cavity and were secured into the holes drilled in 
the VNO. Care was taken to ensure the wires were securely in place (the uninsulated tips 
of the wires are unexposed because they are in place in the holes). Cotton swabs and an 
aspirator were used to dry the tissue thoroughly. A tiny amount of superglue was applied 
to the tip of a 1 mL needle (BD, Franklin Lake, NJ) to glue the wires in place in the 
drilled holes. Once the glue was thoroughly dry, the sutures securing the palate and the 
sides of the mouth open were removed and new sutures were used to loosely stitch the 
palate closed. Mouse was removed from the platform and the skin was superficially cut 
near the protruding twisted wires to expose the wires and skull. The skull was lightly 
scraped with a scalpel to provide an adherent surface for adhesives. All fluid was blotted 
dry and 3% hydrogen peroxide was applied to remove organic material from the skull. 
Twisted wires were coiled onto the top of the skull and glued into place with superglue. 
The two male golden pins connected to the ends of the twisted wires were mounted 
perpendicularly to the skull near each ear so that they are approximately 1 cm apart. C&B 
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metabond dental cement (Parkell, Edgewood, NY) was mixed according to 
manufacturer’s instructions and used to secure the pins in place.  
All precautions were taken to minimize pain and distress during this procedure. 
Following recovery, mice were housed individually in clean cages in our satellite room in 
the animal care facility with softened food and water freely available. Mice were 
monitored daily for signs of distress or infection. Lesion sites were treated with antibiotic 
ointment daily for one week. Any mice showing signs of distress or infection were 
immediately treated or euthanized to minimize discomfort. Mice were allowed to recover 
for at least 5 days following the surgery before the pump recordings occur. 
 
VNO Pump Recording (in vivo): Mice were allowed to recover for at least 5 days 
following surgery before any recordings occur. Mice were temporarily restrained to 
connect golden pin electrodes to appropriate equipment as described in Meredith M, 
1994. Once electrodes were connected, mice were released into a clean arena cage and 
allowed to freely move around to habituate to the cage. Electrode connections did not 
obstruct movement, and based upon the observations in Meredith 1994, animals exhibited 
no signs of distress during the recording. Upon habituation, a petri dish filled with soiled 
bedding from another animal was placed in the cage. Mice were able to freely investigate 
the environment, and behavior and pumping activity were recorded. Mice were treated 
with sildenafil citrate (30 mM) or tadalafil citrate (5 mM) (Sigma-Aldrich, St. Louis, 
MO) via local administration to the tip of the nose. Animals do not exhibit any distress 
from treatment with this drug. Vomeronasal organ pump activity was recorded 15-30 
minutes after drug treatment. VNO pumping was recorded as the change in voltage over 
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time when a 500 Hz, 30 mV constant current was circulated through the tissue. Constant 
current was generated using a Grass Instruments S48 square-pulse generator connected to 
a Grass Stimulus Isolation Unit (to prevent general stimulation propagation). Readout 
was amplified with a dual phase-lock amplifier (EG&G Princeton Applied Research 
model #5210) for all current generated at 500 Hz. Output signal was recorded using 
Axograph 4.9 computer software. After all recordings, mice were temporarily restrained 
to remove electrode connections and returned to their home cage. Trials were repeated. 
Mice were monitored for 2 hours after recording, but did not display any alterations in 
behavior or physical distress after VNO recording procedures. Average amplitude of 
peaks, total number of peaks and peak duration were analyzed.  
 
Superior Cervical Ganglion Stimulation of VNO pump (sympathetic stimulation of 
VNO pump): Adult male mice were intraperitoneally injected with Avertin (250 mg/kg 
body weight). Shoulder was superficially cut to expose pectoralis muscle. Excess fat and 
muscle tissue was carefully extracted to expose the carotid artery, nasopalatine nerve 
bundle, and superior cervical ganglion. Using a Stanford Research Systems Model 
DS345 30MHz Synthesized Function Generator (Sunnyvale, CA), 0.1-1V pulses were 
generated at 10 Hz to the superior cervical ganglion via a dual wire electrode (World 
Precision Instruments, Inc., Sarasota, FL). 
 
VNO Recording (external stimulation of SCG): The SCG was stimulated as described 
previously. VNO pumping was recorded as the change in voltage over time when a 500 
Hz, 30 mV constant current was circulated through the tissue. Constant current was 
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generated using a Grass Instruments S48 square-pulse generator connected to a Grass 
Stimulus Isolation Unit (to prevent general stimulation propagation). Readout was 
amplified with a dual phase-lock amplifier (EG&G Princeton Applied Research model 
#5210) for all current generated at 500 Hz. Output signal was recorded using Axograph 
4.9 computer software. 
 
Statistical analyses: Statistical analyses were all performed with GraphPad Prism 
software. All Student’s t tests were performed assuming Gaussian distribution, two-
tailed, unpaired, and a 95% confidence interval. One-way or two-way ANOVA was used 
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ABSTRACT 
Olfaction is a very elegant system in many species.  In the nose, one olfactory 
sensory neuron expresses only one odor receptor for a particular odor molecule. This 
neuron must then extend its axon to its correct target in the olfactory bulb of the brain.  
This process is crucial for the correct relay of information and identification of odors. 
This primary axonal target process is very precise and many events/mechanisms 
associated with this process are still unknown.  To better understand potential external 
influences for this targeting event, we studied a novel cell population in the olfactory 
nerve layer that axons pass through along their routes of migration to their targets.  Using 
a candidate approach to characterize genes expressed in these cells, we identified the 
unique expression of GluN3A, an NMDA receptor subunit, in these olfactory ensheathing 
cells of the olfactory bulb. We found that genetic ablation of GluN3A did not result in 
changes in overall organization or architecture of the olfactory bulb. Furthermore, using 
OSN-reporter mouse lines, we found that in the absence of GluN3A, OSN axons are still 
able to properly converge onto their glomerular targets in the olfactory bulb. In attempt to 
identify other genes expressed in these cells that might be important for OSN targeting 
processes, we developed a profiling approach to isolate these olfactory ensheathing cells 
to perform RNA sequencing during stages of active axonal targeting. Genes identified in 
this screen may be used to ablate these cells to directly test their role in axonal targeting.   
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INTRODUCTION  
Olfactory ensheathing cells (OECs) are a specialized type of glial cell in the 
olfactory bulb, which surround the outer layers of the olfactory bulb. Although the exact 
factors within these dynamic cells that promote axon survival and function are not fully 
understood, the importance of these cells for critical axon targeting events in the olfactory 
system has long been established (Honore et al., 2012, Wei et al., 2008, Zhu et al., 2010). 
Besides the function of these cells during development within the olfactory system, 
ensheathing cells have also been found to be necessary for proper axonal targeting that 
occurs during active olfactory sensory neuron (OSN) regeneration. Clinical studies have 
focused primarily on the effectiveness of using these cells in spinal cord regeneration 
models to promote proper growth and targeting of motor neurons. While the importance 
of these cells in neuronal targeting events is well known, the unique characteristics these 
cells possess to induce these targeting events are not well established.   
Our laboratory is interested in studying the unique properties of a novel OEC 
subtype and previous work has identified the robust expression of a canonical Wnt 
signaling marker using a transgenic TOPGAL reporter mouse line (Booker-Dwyer et al., 
2008). The expression of this endogenous marker peaks during active stages of OSN 
targeting during both development and chemically-induced regeneration of OSNs. Our 
previous studies have shown OECs expressing the Wnt reporter are negative in 
immunostaining for several glial cell markers including GFAP, p75NTR, RIP, MHC-II, 
CR3/MAC-1, TROY (Booker-Dwyer et al., 2008). Among these glial markers, GFAP, 
p75NTR and TROY are found in other OEC subtypes than those expressing our Wnt 
reporter. To find molecular marker(s) for this OEC subtype, we searched the Allen Brain 
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Atlas in situ database for candidate genes that may be expressed in this OEC subtype in 
the OB. We found the expression of an NMDA receptor subunit, GluN3a, in these OECs 
(http://developingmouse.brain-map.org/gene/show/88952) and decided to investigate this 
intriguing expression pattern.  
The N-methyl-D-aspartate receptor subunit, GluN3A (also known as NR3A or 
NMDAR3A or Grin3A), was first described in the mid-1990s (Ciabarra et al., 1995, 
Sucher et al., 1995), and subsequent studies have shown that expression of GluN3A 
influences synaptic spine density (Das et al., 1998, Roberts et al., 2009), cell survival 
(Nakanishi et al., 2009) and synaptic maturation (Roberts et al., 2009). However, in 
comparison to the classical GluN1 and GluN2 receptor subunits, which have been 
extensively studied, much less information is known about the more recently identified 
GluN3 subunits, as it shares low homology with other NMDA receptor subunits, making 
it difficult to infer its function (Henson et al., 2010).  
Investigations in the brain have shown that GluN3A protein expression is highest 
from birth to early postnatal stages, with expression largely decreasing in later postnatal 
stages into adulthood (Wong et al., 2002). The temporal pattern of expression of this 
subunit throughout development suggests that GluN3A is important during stages of 
migration, differentiation in the brain, and the establishment of functional synapses 
(Ciabarra et al., 1995, Sucher et al., 1995, Wong et al., 2002). In addition to its 
expression in neurons, several recent studies have reported GluN3A expression in 
astrocytes (Lee et al., 2010), oligodendrocytes (Burzomato et al., 2010), as well as other 
non-neuronal cells (Sproul et al., 2011). Expression of GluN3A in the olfactory bulb was 
not previously described until a study in late 2015. 
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The similar temporal and spatial localization of Wnt expression and GluN3a are 
intriguing, and we sought to investigate whether GluN3A is necessary for proper OSN 
targeting to the olfactory bulb during development. While we find no obvious signs of 
improper OSN targeting to the OB when GluN3A is genetically ablated in mice, there 




	   131 
RESULTS 
GluN3A is expressed in OECs within the OB  
In our preliminary studies, we conducted in situ hybridization in cryosections of 
the OB during various stages of development and found that GluN3a exhibited the 
highest expression during early postnatal stages (postnatal day 1, Figure 5.1A; postnatal 
day 5, Figure 5.1B; postnatal day 20, Figure 5.1G). The staining pattern is consistent with 
that seen from the Allen Brain Atlas. We observed no positive staining in sense probe 
controls, or in GluN3A knockout mice (see Figure 5.1E for construct details), which 
confirmed our probe specificity. Thus, GluN3A provides a molecular marker for OECs of 
this subtype to distinguish them from all other cells.  
Since there was a LacZ cassette inserted into the GluN3A locus, we also 
visualized GluN3A expression using a LacZ enzymatic colormetric staining technique, 
X-gal. X-gal staining in GluN3A heterozygous mice shows a specific pattern of 
expression restricted to the OECs (Figure 5.1G-I), and this expression was similar to our 
in situ hybridization staining in age-matched mice (Figure 5.1F, note: in situ development 
was carried out for 6 hours to ensure that the expression was limited to OECs). We next 
used GluN3A knockout mice to assess the consequences of the absence of GluN3A in 
these OECs. 




7953&hgsid=503886315_3k4PzMxv2j6WA6H6i5HQlVW1e54P). So, to further 
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characterize which splice variant of GluN3A was expressed in the olfactory bulb, I 
performed reverse transcription PCR (RT-PCR) with primer pairs specific to the long 
form and short form variants with RNA isolated from the olfactory bulb and brain (as a 
positive control for where GluN3A is known to be highly expressed) from wild type 
mice. Figure 5.2 A, B denotes the approximate location of where the primer sets bind. 
We found that the long form variant is expressed in both the brain and olfactory bulb 
(Figure 5.2C). Furthermore, we extracted the PCR products from the gel and sent the 
samples for sequencing. When we aligned the sequencing results to the mouse genome 
using BLAST software (https://blast.ncbi.nlm.nih.gov), we found that the sequences 
indeed corresponded to the long form of GluN3A from both brain and olfactory bulb 
samples (Figure 5.2D). 
 
Deletion of GluN3A does not perturb general morphology of the olfactory bulb 
Global GluN3A knockout mice (Das et al., 1998) display no gross abnormalities 
(MMRRC repository); however, they have slight motor impairments. We noted these 
motor deficiencies upon the first homozygous knockout litter, and these findings were 
also seen and reported by another laboratory shortly thereafter (Mohamad et al., 2013). 
Up until the point when we received these mice, GluN3A had only been analyzed in 
cortical brain regions. No examination of the olfactory system was reported. 
So, to determine if there were any major effects in the olfactory system of 
GluN3A knockout mice, we collected tissue and immunostained sections of olfactory 
bulb and olfactory epithelium to see if there were any obvious perturbations in the 
olfactory system of these mice. Overall, general morphology of the olfactory bulb was 
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(A) Coronal cryosection of olfactory bulb from postnatal day 1 mice, showing GluN3a 
mRNA localization in the olfactory ensheathing layer (ONL) of the olfactory bulb of the 
main olfactory system (OB). (B-D) Coronal cryosections of olfactory bulb from postnatal 
day 5 mice showing GluN3a mRNA localization in anti-sense stained WT sections (B) 
compared to GluN3A knockout mice (C) and sense-stained WT sections (D). (E) A 
schematic of the construct for the GluN3A KO-LacZ mouse, where a LacZ/Neomycin 
cassette is inserted in place of the first exon of the GluN3A gene. (F) Coronal cryosection 
of olfactory bulb from a WT postnatal day 20 mouse, showing the robust expression of 
GluN3a mRNA in OECs during later postnatal stages. (G) Coronal cryosection of 
olfactory bulb from a GluN3A+/LacZ postnatal day 15 mouse stained with X-gal, 
showing the robust expression of beta-galactosidase activity (as a reporter for GluN3A) 
in OECs. (H-I) Coronal cryosection of OB from a GluN3A+/LacZ postnatal day 40 
mouse, showing the beta-galactosidase reporter activity in OECs during later stages of 
development, with a zoomed-in inset (I) and no positive staining in the olfactory 
epithelium (OE). ONL, olfactory nerve layer. 
 
Note: In situ colormetric development for detection was developed for 2 hours (B-K), and 
6 hours (F). X-gal enzymatic reaction was performed for 3 hours (H, I) and overnight 
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Figure 5.2: The long splice variant of GluN3A is expressed in the brain and 






(A, B) Schematic of the two known splice variants of the GluN3A gene, showing the 
primer pairs used to amplify each variant with RT-PCR.  (C) Gel from RT-PCR to detect 
the 2 splice variants of GluN3A in the brain (lanes 2, 3, positive control) and olfactory 
bulb (lanes 5,6), showing the expression of the long splice variant of GluN3A in both the 
brain and olfactory bulb (lanes 3 and 6, respectively). (D) Resulting sequence from 
Genewiz after gel extraction of OB PCR product from C, which aligns to the long splice 
variant of GluN3A.  
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normal when analyzed with a nuclear fast red stain. Furthermore, we see that olfactory 
marker protein (OMP), which labels all mature OSNs including their axons, is not mis-
expressed or altered in the GluN3A knockout mice. This suggests that there are no 
obvious defects in the global targeting of OSN axons to glomeruli in the OB. When we 
stain with an antibody for tyrosine hydroxylase (TH, a marker for sympathetic neurons), 
we see no differences in localization or amount of TH expression in the olfactory bulb in 
the global knockout mouse (Figure 5.3C, D). 
 
Deletion of GluN3A does not disrupt OSN targeting to the olfactory bulb 
Since GluN3a was expressed in the OECs throughout active stages of OSN axonal 
targeting (Figure 5.1), we wanted to know if GluN3A was required for proper OSN 
axonal targeting to the olfactory bulb during development. To assess whether GluN3A 
was necessary for proper OSN axon targeting, we bred GluN3A-LacZ knockout mice to 
specific M72 and P2 odorant receptor-tau-LacZ-labeled mouse lines (Mombaerts et al., 
1996) and an M71-tau-GFP mouse line (Feinstein and Mombaerts, 2004). The tau-LacZ 
mouse lines utilize beta-galactosidase as a reporter of OSNs that contain the odorant 
receptors P2 and M72. Sparse labeling for these specific receptors allows us to analyze 
the expression and targeting of these OSNs with a simple colormetric X-gal enzymatic 
staining procedure. Furthermore, the fusion of the tau protein with the LacZ enzyme 
allows us to analyze OSN axon targeting to the olfactory bulb. 
  
	  
	   137 





(A-B) Coronal cryosections of olfactory bulb from WT (A) and GluN3A global knockout 
mice (B) stained for olfactory marker protein (OMP), showing normal general targeting 
of olfactory sensory neuron axons to the glomeruli of the olfactory bulb. (C-D) Coronal 
cryosections of olfactory bulb from WT (C) and GluN3A global knockout mice (D), 
showing normal localization and levels of tyrosine hydroxylase (TH) staining in the 
olfactory bulb. Scale bar, A, 100 µm, applies to all images. 
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Figure 5.4: Ablating GluN3A does not affect specific OSN axon targeting to the 
olfactory bulb. 
(A-D) Coronal cryosections of OB from postnatal day 28 (A, B) and postnatal day 2 (C, 
D) mice showing LacZ-labeling of OECs in the olfactory nerve layer of the OB in 
GluN3A heterozygous mice (A, C), or GluN3A knockout mice (B, D). All mice also have 
the P2 olfactory receptor labeled with tau-LacZ to visualize glomerular targeting – see 
inset (A’, B’, C’, D’). (E-F) Coronal cryosections of OB from postnatal day 28 mice 
showing GFP-labeling of M71 OSN axons in the olfactory nerve layer of the OB in 
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When we performed X-gal staining in adult mice (P28), we saw dense labeling of 
OSNs expressing only the P2 (or M72) receptor (Figure 5.4A, B). OSNs expressing the 
same receptor converge onto a glomerular target in the OB, and we see this axon 
fasciculation in both our GluN3A heterozygous mice (Figure 5.4A) and GluN3A 
knockout mice (Figure 5.4B), suggesting that OSN targeting in the OB was fairly normal 
in the absence of GluN3A. Mice of various ages were analyzed and targeting to glomeruli 
appeared grossly normal (postnatal day 2 is also shown in Figure 5.4C, D). 
This result was a bit surprising, given the spatial and temporal pattern of GluN3a 
expression in these cells, but GluN3A may be important for other cellular functions in 
OECs. Therefore, we wanted to analyze other genes of proteins that are known to be 
important for GluN3A function. 
 
GluN1 and GluN2 are not expressed in the OECs of the OB 
GluN3A is a subunit of the NMDA receptor, and its function and dynamics in this 
context have been extensively characterized (Al-Hallaq et al., 2002, Burzomato et al., 
2010, Chatterton et al., 2002, Gallinat et al., 2007, Henson et al., 2012). The Allen Brain 
Atlas in situ hybridization database shows that no other NMDA receptor subunit mRNAs 
(GluN1 and GluN2s) are expressed in the olfactory nerve layer where this novel OEC 
subtype resides. We have confirmed this staining pattern by in situ hybridization for 
GluN1 (Figure 5.5A), and GluN2B (Figure 5.5C) and find that neither of these NMDA 
receptor subunits is expressed in any population of olfactory ensheathing cells (sense 
probes are shown in Figure 5.5B, D). However, GluN1 and GluN2b are clearly expressed 
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 Figure 5.5: GluN1 and GluN2b are not expressed in the OECs of the olfactory bulb. 
 
 
(A) Coronal cryosection of OB from postnatal day 15 mice showing dense GluN1 mRNA 
localization in most regions of the OB, but no GluN1 located in the OECs (arrow). (C) 
Coronal cryosection of OB from postnatal day 15 mice showing dense GluN2B mRNA 
localization in the mitral and granule cell layers of the OB, but no GluN2B located in the 
OECs (arrow). (B) Sense probe for GluN1, (D) Sense probe for GluN2B. OEC, olfactory 
ensheathing cells; GL, glomerular layer; MCL, mitral cell layer.  
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in various neurons in the glomerular layer, mitral cell layer, and granule cell layer of the 
OB, which has been shown in other studies. This absence of other NMDA receptor 
subunits in these GluN3a-positive cells potentially adds more interest in elucidating the 
role of GluN3A specifically in the olfactory system. Using our GluN3A-LacZ 
heterozygous mice, we wanted to visualize the localization of GluN3A in other olfactory-
related regions in the brain.  
 
GluN3A expression in other areas of the olfactory system/general areas of the brain 
While GluN3A has been analyzed in several areas of the brain, expression in the 
olfactory regions of the brain have not been described until very recently. Using the 
GluN3A-LacZ mouse line, we performed X-gal staining in cryosections of brain tissue in 
adult mice. We see expression of GluN3A in the anterior olfactory nucleus (AON) fibers 
(Figure 5.6A, C; see Figure 5.6B, D for detailed brain atlas illustrations). We also see 
GluN3A expression in the olfactory ensheathing cells of the accessory olfactory bulb 
(AOB) (Figure 5.6C). This pattern of staining is not surprising, considering we 
previously saw X-gal staining present in the OECs of the AOB in the TOPGAL 
transgenic mouse line (Booker-Dwyer et al., 2008). This similar expression profile 
suggests a similar role for GluN3A in these OECs in both the main OB and AOB. 
A recent publication reported GluN3A in OSNs in the olfactory epithelium and 
also in mitral cells of the OB, and have suggested a role for GluN3A in OSN function 
(Lee et al., 2015). We have performed X-gal staining with sections containing OE and 
have found no GluN3A expression in OSNs during any stage of development or adult OE 
(Figure 5.1H). This discrepancy is one that needs to be addressed and more careful 
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Figure 5.6: GluN3A is expressed in other olfactory-related areas in the brain. 
(A) Coronal section of the interface of cortex and olfactory bulb, showing LacZ 
expression (a reporter for GluN3A) scattered throughout the cortex and the anterior 
olfactory nucleus (AON) of the olfactory bulb. See schematic (B) from Allen Brain Atlas, 
showing a more detailed structural brain map matching the tissue showed in A. (C) 
Coronal section containing accessory olfactory bulb (AOB) along with the main olfactory 
bulb (OB), showing LacZ expression in the olfactory nerve layer (ONL), accessory 
olfactory bulb (AOB) and the anterior olfactory nucleus (AON) in the center of the main 
OB. See schematic (D) from Allen Brain Atlas, showing a more detailed brain map of the 
regions shown in C. 
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analyses of GluN3A expression in the OB and OE are necessary to uncover the function 
of GluN3A in the olfactory system. We therefore have also optimized a protocol to 
isolate and analyze Wnt-positive and GluN3A-positive OECs using our TOPGAL and 
GluN3A-LacZ mouse lines. 
 
Optimization of a FACS-based protocol to isolate OECs for molecular profiling 
 To employ a more unbiased method to analyze this OEC population, we 
established a protocol to fluorescently sort these cells for characterization. FACS, or 
fluorescence-based cell sorting, will isolate cells expressing GFP with which we can 
extract RNA for genomic profiling. 
 To this date, the only cellular markers uniquely expressed in this OEC population 
were the Wnt-LacZ reporter and GluN3a. Beta-galactosidase is commonly used in the 
laboratory as a reporter for gene expression, so many tools have been developed to use 
this enzyme as a marker (as we did in the GluN3A knockout/LacZ mice). FACS requires 
fluorescence to sort cells, so we needed a system in which β-galactosidase could produce 
or express a fluorescent protein or product. We therefore chose to use an assay that 
utilizes a substrate that is actively cleaved by β-galactosidase to produce a product that 
fluoresces within the cell. We, therefore, choose to use the ImaGene Green™ C12FDG 
lacZ Gene Expression Kit (Molecular Probes). 
First, we dissected the olfactory bulb from TOPGAL and wild type mice during 
early stages of development when active OSN axonal targeting was occurring. We 
dissociated the cells to a single-cell suspension using a combination of methods (Figure 
5.7A-D). We then added media to the single-cells containing the C12FDG (fluorescein-di-
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β galactopyranoside) substrate. β-galactosidase cleaves the substrate into a 
fluorescent product that stays within the cell.  
When we performed this reaction and immediately visualized the cells with a 
fluorescent microscope, we saw labeling of fluorescent cells from the TOPGAL mouse 
olfactory bulb, and none in the wild type sample (Figure 5.7E, F). We then used this 
technique and sorted the cells. Additionally, we used propidium iodide dye as a way to 
label dying cells so that they were not included in these analyses. 
Using a FACS-Vantage sorter (BD Biosciences) at the Johns Hopkins University 
Integrated Imaging Center, we sorted GFP-positive/propidium iodide-negative cells. 
When we sorted cells, we gated for forward and side scatter to determine appropriate cell 
size and fluorescence. When we performed the analysis and looked at the sorted data, we 
observed a set population of cells that were GFP-positive and propidium iodide-negative 
(Figure 5.7G). We sorted a relatively pure population of cells and when we collected 
samples and looked at the fluorescence with a typical epifluorescent microscope, we 
noticed that the population is relatively pure with no cells expressing propidium iodide. 
The optimized conditions for the FACS-based protocol will allow us to perform RNA 
sequencing on the OEC population. Additionally, this assay can be used with GluN3A-
LacZ heterozygous mice and the population of sorted cells derived from these mice can 
also be sequenced to determine if Wnt and GluN3A label the same population of OECs.  
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Figure 5.7: Optimization for FACS of olfactory ensheathing cells. 
(A, C) Dissociated cells from OB after a 15-minute (A) or 30-minute (C) digestion with 
trypsin. (B, D) Dissociated cells from OB after a 15-minute (B) or 30-minute (D) 
digestion with papain. (E-F) GFP fluorescence in dissociated cells from the OB of 
TOPGAL mice (E) and WT mice (F) after reaction with C12FDG fluorescent substrate 
was performed, showing the specificity of the C12FDG reaction for only cells that contain 
b-galactosidase expression (in TOPGAL mice). (G) Fluorescence-Activated Cell Sorting 
(FACS) data showing the isolation of GFP-positive cells that did not stain positive for 
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DISCUSSION 
Until recently, the expression of GluN3A in the olfactory system has not been 
previously reported. While a recent study found GluN3A protein expressed in the OSNs 
in the olfactory epithelium ((Lee et al., 2015)), we have found a different GluN3a 
expression pattern in our laboratory setting. Using a knock-in genetic mouse line where 
LacZ is inserted into the GluN3A locus, we find expression in olfactory ensheathing cells 
of the olfactory bulb, and no expression in any cell type of the olfactory epithelium. With 
in situ hybridization of olfactory tissue, we see the same pattern of expression in OECs, 
especially during developmental stages of active OSN targeting, and an absence of 
expression in the OSNs themselves. We first became interested in this candidate upon 
scanning through the Allen Brain Atlas, a public database containing in situ hybridization 
staining of numerous genes in brain tissue sections from embryonic to adult stages of 
development. This database also shows GluN3a highly expressed specifically in OECs of 
the olfactory bulb (http://developingmouse.brain-map.org/experiment/show/100041391) 
during early postnatal stages. 
This database as well as our preliminary studies (Figure 5.5) also show that no 
other NMDA receptor subunits (GluN1 and GluN2s) are expressed in the olfactory nerve 
layer where this novel OEC subtype resides. This is greatly surprising and intriguing, 
because it has been shown that GluN3A is not capable of constituting a functional 
homomeric NMDA receptor and needs GluN1 to form a functional glutamate receptor 
(Madry et al., 2010, Perez-Otano et al., 2001). GluN3A has never been shown to function 
beyond its role in forming NMDA receptors (Henson et al., 2010). The expression of 
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GluN3A in this subtype of OECs thus suggests a novel non-canonical function of 
GluN3A in olfactory glial cells.  
It has also been shown that without GluN1, GluN3A is not able to exit the ER 
(Atlason et al., 2007, Schuler et al., 2008). The expression pattern we see suggests a 
novel role of GluN3A in the olfactory system. It would be interesting to use GluN3A as a 
marker of OECs to perform FACS and sequencing. According to our data, it appears that 
GluN3A is expressed in OECs throughout adulthood, albeit at a lower level than during 
development. It would be interesting to uncover the function of GluN3A in these cells, 
especially during these developmental stages.  
Our preliminary studies have shown that GluN3A does not play an essential role 
in regulating general OB structure or in the targeting of OSNs to glomeruli in the OB, 
since ablating GluN3A does not result in any obvious defects within the OB itself, or 
targeting defects when analyzing LacZ reporters for particular OSNs (Figure 5.4). 
Although GluN3A does not appear to be necessary for OSN targeting, it may still play a 
role in OSN axon sorting. Since we know nothing about its function other than in forming 
active NMDA receptors, there are many possibilities for its role in OECs. The 
identification of GluN3A binding partners in OECs may provide functional insight. 
The work outlined in this chapter has not shown conclusive functions of GluN3A 
in this particular GluN3A-expressing OEC population; however, our efforts to optimize a 
protocol to effectively sort and sequence this OEC population could be useful for 
revealing other potential candidates that are essential for the function of these cells. The 
uses of these cells in promoting and controlling axon targeting in other systems, 
especially those involving spinal cord injuries, have elicited the need to determine the 
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function of individual subtypes of OECs to suit the needs of the translational system. 
Many spinal cord injury models have resulted in a variety of outcomes after OEC 
transplantation, and many of these results have been proposed to be attributed to the 
heterogeneous population of OECs from the OB (Richter and Roskams, 2008). Therefore, 
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METHODS 
Tissue preparation for X-gal stain: GluN3A-/- mice were bred with M72tauLacZ+/+; 
GluN3A+/- mice to produce offspring that are M72tauLacZ+/-; GluN3A-/- and 
M72tauLacZ+/-; GluN3A+/-. At various timepoints during development, mice were 
sacrificed (P0.5, P7, P14, P21, P28). Early timepoints (P0.5, P7) were dissected and 
heads were fixed in 4% paraformaldehyde for 2 hours. Later timepoints (P14, P21, P28) 
were transcardially perfused with 4% paraformaldehyde and decalcified in 10% EDTA 
for 4-6 days. After fixation and decalcification, tissue was cryoprotected with 30% 
sucrose overnight and then embedded in Tissue Tek OCT Compound (VWR). The 
embedded head was cut and 35 µm coronal cryosections of the olfactory bulb were 
collected using a cryostat (Thermo-Fisher Scientific) and mounted onto Superfrost plus 
slides (Fisherbrand). Slides were dried overnight and stored at -80°C until use. 
X-gal staining: Olfactory bulb cryosections were removed from -80°C freezer and 
allowed to air dry at room temperature for 10 minutes. Sections were rehydrated in 0.1M 
PBS for 10 minutes at room temperature and immersed in X-gal staining solution 
(100mg/mL X-gal with 0.025g/mL ferrocyanide, 0.040g/mL ferricyanide) a few hours to 
overnight at room temperature in a dark chamber. Slides were then fixed in 4% 
paraformaldehyde (Sigma-Aldrich) for 15 minutes at room temperature and residual X-
gal precipitate was removed with 70% ethanol treatment. Slides were counterstained with 
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Antibodies used for Immunohistochemistry: 
Antibody Species Dilution Ordering Info 
β-galactosidase Chicken 1:500 Millipore #AB3403 
OMP Goat 1:1000 Margolis Lab, UMD 
Tyrosine Hydroxylase (TH) Rabbit 1:500 Millipore  #AB152 
 
Reverse Transcription: Adult mice (>2 months of age) were intraperitoneally injected 
with 250 mg/kg body weight Avertin (Sigma), and the olfactory bulb and brain were 
immediately dissected and homogenized in TriZol (Life Technologies). RNA was 
extracted using phenol-chloroform. Primer sets were designed to recognize two variants 
of GluN3A. RT reactions were run with 0.5 µg of total RNA for all reactions.  
Primers for GluN3A long variant (predicted band size: 1214 bp): 
GCACAATGAACTGCATGGATGTG; CCTTCTCATGTACTCATGCATCTC 
Primers for GluN3A short variant (predicted band size: 1469 bp): 
 GCACAATGAACTGCATGGATGTG; GCATACAAGCAGTCAACCTTGAAG 
 
GluN3A/GluN1/GluN2B in situ hybridization: All methods described were modified 
from Ishii et al., 2004. Riboprobe templates for GluN3A, GluN1, and GluN2B were 
created using cDNA from brain tissue. Templates were cloned into the TOPO-TA vector 
(Thermo-Fisher, Waltham, MA). Plasmids were then linearized using BamHI and XbaI 
restriction enzymes (New England Biolabs, Ipswich, MA). Linearized plasmids were 
phenol-chloroform purified for in vitro transcription reactions. BamHI-cut inserts were 
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transcribed with T7 RNA polymerase (Invitrogen, Grand Island, NY) and XbaI-cut 
inserts were transcribed with Sp6 RNA polymerase (Ambion, Grand Island, NY). All 
solutions used prior to probe hybridization were made with diethylpyrocarbonate 
(DEPC)-treated solutions (Sigma-Aldrich, St. Louis, MO). OB cryosections were post-
fixed in 4% paraformaldehyde for 15 minutes at room temperature and washed in 0.1M 
PBS/DEPC. Tissue was digested with Proteinase K (10ug/mL in TE buffer) for 10 
minutes at 37°C and post-fixed in 4% PFA for 10 minutes at room temperature. Slides 
were washed in 0.1M PBS/DEPC and incubated in 0.2N HCl for 20 minutes. Slides were 
acetylated and dehydrated subsequently in 60%, 80%, 95%, 100% and 100% ethanol. 
Samples were air-dried for 10 minutes and equilibrated in Hybridization Buffer for 1 
hour at room temperature in a humid chamber. Probes were diluted in Hybridization 
Buffer (0.1-0.3 µg/100 µL) and heated at 85°C for 3 minutes to prevent secondary 
structure formation. 100-150 µL of probe/hybridization buffer mix was applied to 
coverslips and slides were inverted and placed face-down onto coverslips. Probes were 
hybridized for 12-16 hours in a humid chamber set to 65°C. Following overnight 
hybridization, coverslips were removed from slides using 65°C-prewarmed 5X SSC. 
Slides were washed in 2XSSC/50% formamide for 30 minutes at 55°C and then in 0.2X 
SSC (x3) at 55°C. Slides were equilibrated in 10% donkey serum block (TNB buffer) for 
1 hour at room temperature in a humidified chamber. Anti-DIG-AP Fab Fragment 
antibody (Invitrogen, Grand Island, NY) was diluted 1:5000 in TNB buffer and 200 µL 
of antibody/TNB buffer mix was applied to each slide, covered with strips of parafilm to 
prevent solution evaporation and incubated at 4°C overnight. After 12-16 hours, slides 
were washed in TN buffer for 5 minutes each at room temperature (x4) and then 
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equilibrated in a magnesium-based buffer for 10 minutes at room temperature. 1 
NBT/BCIP tablet (Roche) was dissolved in 10 mL of distilled water and precipitate was 
removed using a sterile filter. Solution was generously applied to slides and slides were 
kept in the dark for 2-6 hours and monitored intermittently for alkaline phosphate 
colormetric precipitate, using sense-treated slides as controls for each gene. Slides were 
then washed in 0.1M PBS and sterile water and cover-slipped with Fluoromount aqueous 
mounting medium (Sigma-Aldrich). 
GluN3A/Grin3A/NR3A anti-sense probe primers (611 bp): 
CATCGTCAGCTCAGAAAACAAC; GTCCTCACTAAGATGCCCAAAC 
GluN1/Grin1/NR1 anti-sense primers (844 bp): 
ACGGGGCCTAATGACACA; ATGGCCTCAGCTGCACTC 
GluN2B/Grin2B/NR2B anti-sense primers (694 bp): 
TAGCTATAGAGGAGCGCCAATC; CTCGATTTCATCAAACTCCCTC 
 
OEC dissociation and beta-galactosidase fluorescent assay: Olfactory bulb tissue was 
dissected from postnatal day 5 (P5) mice, briefly minced with fine surgical scissors, and 
digested in solution containing 0.2% papain (Worthington #LS003126), 50 mM L-
cysteine, 10 mM EDTA dissolved in HBSS, or solution containing 0.25% trypsin 
(Worthington #LS003707) for 15 and 30 minutes at 37°C to dissociate tissue into single 
cells for sorting. After digestion, dissociated tissue was filtered through a 0.2 µm filter 
(Corning) and used for an ImaGene Green C12FDG LacZ gene expression assay 
(Molecular Probes #I2904) performed according to manufacturer’s instructions. Briefly, 
after dissociation, cells were incubated in C12FDG substrate (33 µM) for 30 minutes at 
37°C. Cells were then removed and viewed with standard fluorescence microscopy to 
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visualize fluorescent LacZ product formation. Immediately after the LacZ fluorescent 
reaction, cells were placed into BSA buffer with 1 µg/mL propidium iodide (Invitrogen 












CHAPTER 6: CONCLUDING REMARKS 
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The olfactory system is often overlooked as a vital sensory system for humans; 
however, deficits in olfactory function greatly impact the lives of those affected. The 
dynamic nature of this sensory system is remarkable – olfactory sensory neurons are able 
to stochastically choose one particular receptor to express out of over a thousand and 
upon expressing this receptor, correctly find their targets in the olfactory bulb. It is the 
combination of various chemicals binding their cognate receptors on OSNs that 
constitutes a particular odor that we perceive. The sense of smell contributes to a large 
portion of the tastes we enjoy, and can strongly affect our mood.  
The neurons of this system can regenerate from a local reservoir of stem cells, 
even during adulthood upon damage to the tissue, which also makes this system 
incredibly interesting as a model for studying neuronal regeneration. Studies have even 
shown that the high sensitivity of this system can be used as an early indicator of 
neurodegenerative disease. Recent research in the olfactory field is now dedicated to 
studying the influence and conditioning of smell to satiate one’s appetite for weight loss 
purposes. These are just some of the points that demonstrate the importance of the sense 
of smell in the everyday lives of humans. Non-primate mammalian species strongly rely 
on the ability to detect odors and pheromones for survival. In many of these animals, 
vision is limited, so much of the information that the animal gathers about its 
environment is through its ability to detect odors from the environment. 
We have analyzed both the main and accessory olfactory systems in mice using 
genetic and pharmacological approaches to study the importance of specific proteins in 
these respective systems. These studies have focused on the function of GluN3A within 
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the olfactory ensheathing cells of the main olfactory bulb, and the importance of PDE5A 
in the VNO pump for the transport of pheromones to the VNO. 
  
OSN axon targeting in the olfactory system 
 Another unique feature of the olfactory system is the supporting glial cell 
population that guides OSN axons to their correct targets in the olfactory bulb, during 
both developmental targeting as well as re-targeting during regeneration. While these 
glial cells are fundamentally important for the olfactory system because they promote 
axon growth and targeting in this system, they have also been utilized for therapeutic 
purposes. They have been used extensively in spinal cord injury models to promote 
migration and targeting of these axons to restore neuronal function (described below). 
While the clinical use of these unique cells has grown substantially in the neuro-
regeneration field, there still is a lot unknown about these specialized glial cells. It is 
interesting to investigate how these glial cells promote axon path-finding because after 
neuronal injury or damage, many glial cell types (Schwann cells and some astrocytes) 
actually hinder axonal targeting, suppressing the neurons’ abilities to innervate their 
targets (Chen et al., 2002a, Chen et al., 2002b, Mukhopadhyay et al., 1994, Shen et al., 
1998). People have been trying to pinpoint the factor(s) these cells secrete, produce, or 
respond to that initiate these targeting events.  
 Our laboratory has investigated some of the properties of these cells within the 
olfactory system, and has identified particular Wnt and GluN3a expression within these 
OECs. Wnt signaling and GluN3a are also temporally expressed during stages in which 
active OSN axon targeting takes place. The OSN axons are ensheathed by these glial 
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cells and the axons extend directly through this layer of cells on their way to their 
glomerular target in the olfactory bulb. It is compelling to speculate how these OECs 
interact with the growing axons and their environment to promote such fine-tuned 
mechanisms for proper targeting.  
 The work in this dissertation primarily focused on the spatial and temporal 
expression patterns of the NMDA receptor subunit, GluN3A, in the OECs. These 
expression patterns made GluN3A an attractive candidate for studying the role of OECs 
during OSN axon targeting. The novelty of this gene in the ensheathing cells was 
intriguing and the time-points in which it was expressed led us to hypothesize that it may 
play an active role in the targeting process.  
 
Speculation about GluN3A function in OECs 
NMDA receptors constitute a unique class of ionotropic receptors, and recognize 
the most common excitatory neurotransmitter in the brain, glutamate. They have been 
shown to be critical for synaptic plasticity as well as cortical development (Lau and 
Zukin, 2007, McBain and Mayer, 1994, Cull-Candy et al., 2001), largely due to their 
permeability to calcium. NMDA receptors are hetero-tetrameric channels (Laube et al., 
1998, Rosenmund et al., 1998) consisting of various combinations of GluN1, GluN2 and 
GluN3 subunits (Figure 1.3) (Furukawa et al., 2005, Schorge and Colquhoun, 2003). 
Whereas GluN1 is the most well-studied and has been implicated as an essential subunit 
for channel formation, GluN2 and GluN3 subunits grant unique properties to NMDA 
receptors with different subunit compositions. Many studies have focused on the relative 
expression levels of GluN2A/GluN2B subunits throughout development and the spatio-
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temporal expression of these subunits has been correlated to synaptic plasticity in the 
nervous system. 
The only function of GluN3A that has been characterized to this date has been its 
role as an NMDA receptor subunit (Henson et al., 2010); however, our studies have 
shown that no other NMDA receptor subunits (especially GluN1) are expressed in this 
OEC subtype (see Chapter 5 for details). This suggests a novel function for GluN3A in 
these cells, and it is intriguing to elucidate the role of GluN3A in the ensheathing cells, 
considering the unique properties of these cells in axonal targeting. Further studies are 
needed to identify potential binding partners for GluN3A in OECs to determine its 
function within these cells. 
The work outlined in Chapter 5 did not yield a definitive role for GluN3A in OSN 
axon targeting. Globally ablating GluN3A did not result in a deficit in OSN targeting to 
OB glomeruli. While no obvious defects in OB structure or targeting were noted, more 
detailed analyses of GluN3A ablating in the olfactory system may reveal a novel function 
of GluN3A in this system. Although our studies focused on GluN3A in OECs particularly 
in the context of OSN targeting, OECs have also been used to promote axon targeting in 
other neuronal systems. The therapeutic potential for OECs in other systems makes 
elucidating the role of GluN3A in these OECs even more intriguing to study. 
 
Olfactory ensheathing cells can promote axon outgrowth and proper targeting in 
neuronal systems other than the olfactory system	  
During the past two decades, OEC transplantation has emerged as one of the most 
promising experimental approaches for nervous system repair (Ramon-Cueto and Avila, 
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1998, Zhu et al., 2010). Unlike OSNs, OECs respond well to being isolated and cultured 
(Richter et al., 2008, Jani and Raisman, 2004) for transplantation. This translational 
prospect has been warranting enormous research efforts to advance understanding of both 
OEC biology and the molecular mechanisms by which OECs assist in axonal 
regeneration. Despite this limited understanding of OEC biology, the remarkable 
capability of OECs in promoting OSN axonal growth has triggered interest in using 
OECs to promote repair of injury to the brain and spinal cord, where regeneration does 
not occur spontaneously.  
Ever since the initial trials of successful experiments in rats showing that OEC 
transplantation promotes regeneration of transected dorsal root axons back into the spinal 
cord (Ramon-Cueto and Nieto-Sampedro, 1994) and axon regeneration in injured spinal 
cord (Li et al., 1997, Ramon-Cueto and Avila, 1998, Ramon-Cueto et al., 1998, Ramon-
Cueto and Valverde, 1995, Richter et al., 2005, Richter and Roskams, 2008), OECs have 
been extensively tested in various nervous system lesion models. Most of these studies 
report positive results in repairing, but considerable variation in the functional or 
anatomical outcome exist (Richter and Roskams, 2008). The variability in this outcome 
reported in OEC transplantation studies has been attributed in part to the heterogeneous 
nature of the OEC population and the lack of specific molecular markers for different 
OEC subtypes, which may each differentially play a role in facilitating the regenerative 
process (Richter and Roskams, 2008). It is therefore necessary to characterize the diverse 
subtypes of OECs within the olfactory nerve layer and identify unique properties of these 
cells that could be responsible for facilitating axon outgrowth and retargeting. Although 
the findings from our work have not uncovered an essential regulatory role for GluN3A 
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in the olfactory system, it still provides a novel molecular marker for these OECs to 
further study their unique axon outgrowth-promoting abilities. 
 
The Vomeronasal System 
 While quite a bit is known about the main olfactory system, much less is known 
about the accessory olfactory system, the vomeronasal system, which is primarily 
responsible for detecting pheromones in non-primate mammals. While this system may 
be less critical for human medicinal purposes, understanding of the unique properties of 
this system can provide a lot of insight about molecular processes applicable to disease 
and treatment.  
 One of the least-studied aspects of the vomeronasal organ is the transport of 
pheromones into the cavity containing the sensory neurons. Unlike the main olfactory 
system, pheromones cannot passively diffuse into the organ to be detected, the delivery 
process involves an active mechanism of transport. The exact purposes for this active 
transport are not known, but speculations of its importance involve the potential 
vulnerability of the vomeronasal system – it has been suggested that stimuli are only 
delivered to the VNO upon active pumping to protect the VSNs from exposure to 
environmental toxins or inappropriate stimuli (Meredith, 1994). Another proposal is that 
mucus secreted from nasal glands is needed for transport of pheromones to the VNO, and 
this secretion is stimulated by the VNO pumping mechanism; therefore, passive transport 
is not sufficient for providing mucosal secretions and must be triggered by an active 
mechanism (Meredith, 1991, Meredith, 1994). 
 A few studies have attempted to determine the important components of this 
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system, and they have found that pheromone transport into the VNO is reliant upon a 
blood vessel-based pumping mechanism (Meredith, 1994, Meredith et al., 1980, Meredith 
and O'Connell, 1979). The VNO is surrounded by stiff bony tissue, and this rigid 
encapsulation of the tissue induces a suctioning or expulsion force when there are any 
pressure changes in the organ. The main blood vessel of the VNO fills a large portion of 
the organ, and it is probable that the pulsing dynamics of this blood vessel regulate the 
drawing in or expulsion of fluid containing pheromones or odors.  
 While previous studies have determined the dynamics of the VNO pumping 
mechanism and the neuronal fibers responsible for initiating the pump, our work 
demonstrates a potential molecular mechanism for this process. Furthermore, we have 
introduced a novel way to acutely and reversibly attenuate the VNO pump without 
genetic or surgical methods. Although we have identified PDE5A as being an important 
component of VNO pump dynamics, it is also necessary to investigate other proteins in 
the nitric oxide signaling pathway that we have shown to be expressed, since they may 
also play essential roles in regulating the VNO blood vessel.  
 
Final Thoughts 
 Overall, the outcomes of this work have focused on two less-studied aspects of 
the olfactory system – the olfactory ensheathing cells of the main olfactory system and 
the vomeronasal pump of the accessory olfactory system. While it may seem insignificant 
to study these particular topics, knowledge of the importance of these processes can also 
be applicable for other purposes. Olfactory ensheathing cells are readily used for 
translational applications, and any further understanding of these cells can greatly impact 
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this growing field. The regulatory mechanisms controlling the VNO blood vessel pump 
can also advance our knowledge about general mechanisms underlying blood vessel 
dynamics. The development of various tools and markers described in this dissertation 
can also be utilized for further use in general olfactory-related research.  
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